JP2011162490A - Highly-conjugated compound, precursor thereof, and method for producing highly-conjugated compound - Google Patents
Highly-conjugated compound, precursor thereof, and method for producing highly-conjugated compound Download PDFInfo
- Publication number
- JP2011162490A JP2011162490A JP2010028231A JP2010028231A JP2011162490A JP 2011162490 A JP2011162490 A JP 2011162490A JP 2010028231 A JP2010028231 A JP 2010028231A JP 2010028231 A JP2010028231 A JP 2010028231A JP 2011162490 A JP2011162490 A JP 2011162490A
- Authority
- JP
- Japan
- Prior art keywords
- formula
- mmol
- hydrogen atom
- represented
- halogenated
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 138
- 239000002243 precursor Substances 0.000 title claims abstract description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 15
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims description 54
- 125000001931 aliphatic group Chemical group 0.000 claims description 35
- 125000001424 substituent group Chemical group 0.000 claims description 31
- 229910052731 fluorine Inorganic materials 0.000 claims description 24
- 125000001153 fluoro group Chemical group F* 0.000 claims description 24
- 125000004093 cyano group Chemical group *C#N 0.000 claims description 23
- 239000011203 carbon fibre reinforced carbon Substances 0.000 claims description 13
- 150000008282 halocarbons Chemical group 0.000 claims description 7
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 claims description 5
- 229910052801 chlorine Inorganic materials 0.000 claims description 5
- 125000001309 chloro group Chemical group Cl* 0.000 claims description 4
- 230000002194 synthesizing effect Effects 0.000 claims description 2
- 125000001183 hydrocarbyl group Chemical group 0.000 claims 7
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical group C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 abstract description 31
- 230000001590 oxidative effect Effects 0.000 abstract description 6
- 230000005669 field effect Effects 0.000 abstract description 3
- 239000004020 conductor Substances 0.000 abstract description 2
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract description 2
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 238000006243 chemical reaction Methods 0.000 description 94
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 89
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 75
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 68
- 239000000243 solution Substances 0.000 description 68
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 44
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 43
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 42
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 39
- 230000015572 biosynthetic process Effects 0.000 description 32
- 238000003786 synthesis reaction Methods 0.000 description 32
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 30
- ZQBFAOFFOQMSGJ-UHFFFAOYSA-N hexafluorobenzene Chemical compound FC1=C(F)C(F)=C(F)C(F)=C1F ZQBFAOFFOQMSGJ-UHFFFAOYSA-N 0.000 description 28
- 239000000203 mixture Substances 0.000 description 27
- 238000005160 1H NMR spectroscopy Methods 0.000 description 25
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 22
- 229910052757 nitrogen Inorganic materials 0.000 description 22
- 238000010898 silica gel chromatography Methods 0.000 description 22
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 18
- 125000000168 pyrrolyl group Chemical group 0.000 description 17
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical group [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 16
- 229910052740 iodine Inorganic materials 0.000 description 16
- 229910000104 sodium hydride Inorganic materials 0.000 description 16
- 238000001816 cooling Methods 0.000 description 15
- 150000002430 hydrocarbons Chemical group 0.000 description 15
- 239000011630 iodine Substances 0.000 description 15
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 description 14
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 13
- 229910052938 sodium sulfate Inorganic materials 0.000 description 13
- 235000011152 sodium sulphate Nutrition 0.000 description 13
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 238000003756 stirring Methods 0.000 description 12
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 description 11
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 description 11
- 229910000024 caesium carbonate Inorganic materials 0.000 description 11
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 11
- 238000005481 NMR spectroscopy Methods 0.000 description 10
- DLEDOFVPSDKWEF-UHFFFAOYSA-N lithium butane Chemical compound [Li+].CCC[CH2-] DLEDOFVPSDKWEF-UHFFFAOYSA-N 0.000 description 10
- 238000007254 oxidation reaction Methods 0.000 description 10
- 239000012141 concentrate Substances 0.000 description 9
- MZRVEZGGRBJDDB-UHFFFAOYSA-N n-Butyllithium Substances [Li]CCCC MZRVEZGGRBJDDB-UHFFFAOYSA-N 0.000 description 9
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical class O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 9
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 239000000460 chlorine Substances 0.000 description 8
- 238000001840 matrix-assisted laser desorption--ionisation time-of-flight mass spectrometry Methods 0.000 description 8
- 239000012044 organic layer Substances 0.000 description 8
- 230000003647 oxidation Effects 0.000 description 8
- 238000000746 purification Methods 0.000 description 8
- 238000010992 reflux Methods 0.000 description 8
- 229920006395 saturated elastomer Polymers 0.000 description 8
- 238000001644 13C nuclear magnetic resonance spectroscopy Methods 0.000 description 7
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 7
- 125000002029 aromatic hydrocarbon group Chemical group 0.000 description 7
- 239000006185 dispersion Substances 0.000 description 7
- 239000000706 filtrate Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- 239000002480 mineral oil Substances 0.000 description 7
- 235000010446 mineral oil Nutrition 0.000 description 7
- -1 2,2-dimethylethyl group Chemical group 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 6
- 238000004458 analytical method Methods 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 238000001953 recrystallisation Methods 0.000 description 6
- 150000003839 salts Chemical class 0.000 description 6
- 229940079827 sodium hydrogen sulfite Drugs 0.000 description 6
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 6
- LPXPTNMVRIOKMN-UHFFFAOYSA-M sodium nitrite Chemical compound [Na+].[O-]N=O LPXPTNMVRIOKMN-UHFFFAOYSA-M 0.000 description 6
- PCRSJGWFEMHHEW-UHFFFAOYSA-N 2,3,5,6-tetrafluorobenzene-1,4-dicarbonitrile Chemical compound FC1=C(F)C(C#N)=C(F)C(F)=C1C#N PCRSJGWFEMHHEW-UHFFFAOYSA-N 0.000 description 5
- 239000007787 solid Substances 0.000 description 5
- 238000005406 washing Methods 0.000 description 5
- HWIPMBCMGVXOKN-UHFFFAOYSA-N 2,3,5,6-tetrafluoropyridine Chemical compound FC1=CC(F)=C(F)N=C1F HWIPMBCMGVXOKN-UHFFFAOYSA-N 0.000 description 4
- 125000005843 halogen group Chemical group 0.000 description 4
- 239000007800 oxidant agent Substances 0.000 description 4
- 238000010791 quenching Methods 0.000 description 4
- 239000000126 substance Substances 0.000 description 4
- XTGOWLIKIQLYRG-UHFFFAOYSA-N 2,3,4,5,6-pentafluoropyridine Chemical compound FC1=NC(F)=C(F)C(F)=C1F XTGOWLIKIQLYRG-UHFFFAOYSA-N 0.000 description 3
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 229910052736 halogen Inorganic materials 0.000 description 3
- 150000002367 halogens Chemical class 0.000 description 3
- 239000010410 layer Substances 0.000 description 3
- 238000004768 lowest unoccupied molecular orbital Methods 0.000 description 3
- 230000000171 quenching effect Effects 0.000 description 3
- 239000011541 reaction mixture Substances 0.000 description 3
- 239000004065 semiconductor Substances 0.000 description 3
- 235000010288 sodium nitrite Nutrition 0.000 description 3
- 238000000859 sublimation Methods 0.000 description 3
- 230000008022 sublimation Effects 0.000 description 3
- SDXUIOOHCIQXRP-UHFFFAOYSA-N 1,2,4,5-tetrafluorobenzene Chemical compound FC1=CC(F)=C(F)C=C1F SDXUIOOHCIQXRP-UHFFFAOYSA-N 0.000 description 2
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 description 2
- QZSZOAHYEWOVOC-UHFFFAOYSA-N 3,4-dipentyl-1h-pyrrole Chemical compound CCCCCC1=CNC=C1CCCCC QZSZOAHYEWOVOC-UHFFFAOYSA-N 0.000 description 2
- WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical group [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- MHAJPDPJQMAIIY-UHFFFAOYSA-N Hydrogen peroxide Chemical compound OO MHAJPDPJQMAIIY-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 2
- 238000000862 absorption spectrum Methods 0.000 description 2
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 2
- ROOXNKNUYICQNP-UHFFFAOYSA-N ammonium persulfate Chemical compound [NH4+].[NH4+].[O-]S(=O)(=O)OOS([O-])(=O)=O ROOXNKNUYICQNP-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 238000004440 column chromatography Methods 0.000 description 2
- ORTQZVOHEJQUHG-UHFFFAOYSA-L copper(II) chloride Chemical compound Cl[Cu]Cl ORTQZVOHEJQUHG-UHFFFAOYSA-L 0.000 description 2
- 238000002425 crystallisation Methods 0.000 description 2
- 230000008025 crystallization Effects 0.000 description 2
- 125000004122 cyclic group Chemical group 0.000 description 2
- YADSGOSSYOOKMP-UHFFFAOYSA-N dioxolead Chemical compound O=[Pb]=O YADSGOSSYOOKMP-UHFFFAOYSA-N 0.000 description 2
- 239000003792 electrolyte Substances 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- 230000003993 interaction Effects 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- NUJOXMJBOLGQSY-UHFFFAOYSA-N manganese dioxide Chemical compound O=[Mn]=O NUJOXMJBOLGQSY-UHFFFAOYSA-N 0.000 description 2
- 238000001819 mass spectrum Methods 0.000 description 2
- 229910001510 metal chloride Inorganic materials 0.000 description 2
- 239000010446 mirabilite Substances 0.000 description 2
- 125000002950 monocyclic group Chemical group 0.000 description 2
- KMUONIBRACKNSN-UHFFFAOYSA-N potassium dichromate Chemical compound [K+].[K+].[O-][Cr](=O)(=O)O[Cr]([O-])(=O)=O KMUONIBRACKNSN-UHFFFAOYSA-N 0.000 description 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 2
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 description 2
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical compound CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 2
- 238000005979 thermal decomposition reaction Methods 0.000 description 2
- AVQQQNCBBIEMEU-UHFFFAOYSA-N 1,1,3,3-tetramethylurea Chemical compound CN(C)C(=O)N(C)C AVQQQNCBBIEMEU-UHFFFAOYSA-N 0.000 description 1
- YIWGJFPJRAEKMK-UHFFFAOYSA-N 1-(2H-benzotriazol-5-yl)-3-methyl-8-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carbonyl]-1,3,8-triazaspiro[4.5]decane-2,4-dione Chemical compound CN1C(=O)N(c2ccc3n[nH]nc3c2)C2(CCN(CC2)C(=O)c2cnc(NCc3cccc(OC(F)(F)F)c3)nc2)C1=O YIWGJFPJRAEKMK-UHFFFAOYSA-N 0.000 description 1
- HMUNWXXNJPVALC-UHFFFAOYSA-N 1-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)C(CN1CC2=C(CC1)NN=N2)=O HMUNWXXNJPVALC-UHFFFAOYSA-N 0.000 description 1
- NLUMYBPYUIDFJZ-UHFFFAOYSA-N 2,3-dihexyl-1h-pyrrole Chemical compound CCCCCCC=1C=CNC=1CCCCCC NLUMYBPYUIDFJZ-UHFFFAOYSA-N 0.000 description 1
- VZSRBBMJRBPUNF-UHFFFAOYSA-N 2-(2,3-dihydro-1H-inden-2-ylamino)-N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]pyrimidine-5-carboxamide Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C(=O)NCCC(N1CC2=C(CC1)NN=N2)=O VZSRBBMJRBPUNF-UHFFFAOYSA-N 0.000 description 1
- LDXJRKWFNNFDSA-UHFFFAOYSA-N 2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]ethanone Chemical compound C1CN(CC2=NNN=C21)CC(=O)N3CCN(CC3)C4=CN=C(N=C4)NCC5=CC(=CC=C5)OC(F)(F)F LDXJRKWFNNFDSA-UHFFFAOYSA-N 0.000 description 1
- LCPVQAHEFVXVKT-UHFFFAOYSA-N 2-(2,4-difluorophenoxy)pyridin-3-amine Chemical compound NC1=CC=CN=C1OC1=CC=C(F)C=C1F LCPVQAHEFVXVKT-UHFFFAOYSA-N 0.000 description 1
- 125000004493 2-methylbut-1-yl group Chemical group CC(C*)CC 0.000 description 1
- OFLRJMBSWDXSPG-UHFFFAOYSA-N 3,4,5,6-tetrafluorobenzene-1,2-dicarbonitrile Chemical compound FC1=C(F)C(F)=C(C#N)C(C#N)=C1F OFLRJMBSWDXSPG-UHFFFAOYSA-N 0.000 description 1
- YLZOPXRUQYQQID-UHFFFAOYSA-N 3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)-1-[4-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]piperazin-1-yl]propan-1-one Chemical compound N1N=NC=2CN(CCC=21)CCC(=O)N1CCN(CC1)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F YLZOPXRUQYQQID-UHFFFAOYSA-N 0.000 description 1
- XWNSFEAWWGGSKJ-UHFFFAOYSA-N 4-acetyl-4-methylheptanedinitrile Chemical compound N#CCCC(C)(C(=O)C)CCC#N XWNSFEAWWGGSKJ-UHFFFAOYSA-N 0.000 description 1
- DEXFNLNNUZKHNO-UHFFFAOYSA-N 6-[3-[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperidin-1-yl]-3-oxopropyl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1CCN(CC1)C(CCC1=CC2=C(NC(O2)=O)C=C1)=O DEXFNLNNUZKHNO-UHFFFAOYSA-N 0.000 description 1
- SWKVSFPUHCMFJY-UHFFFAOYSA-N 6-methyl-2-oxo-5-pyridin-4-yl-1h-pyridine-3-carboxamide Chemical compound N1C(=O)C(C(N)=O)=CC(C=2C=CN=CC=2)=C1C SWKVSFPUHCMFJY-UHFFFAOYSA-N 0.000 description 1
- FWLUTJHBRZTAMP-UHFFFAOYSA-N B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+] Chemical compound B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.B([O-])([O-])F.[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+].[Li+] FWLUTJHBRZTAMP-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 229910021592 Copper(II) chloride Inorganic materials 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 1
- MKYBYDHXWVHEJW-UHFFFAOYSA-N N-[1-oxo-1-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propan-2-yl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(C(C)NC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 MKYBYDHXWVHEJW-UHFFFAOYSA-N 0.000 description 1
- NIPNSKYNPDTRPC-UHFFFAOYSA-N N-[2-oxo-2-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)ethyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 NIPNSKYNPDTRPC-UHFFFAOYSA-N 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- GRYLNZFGIOXLOG-UHFFFAOYSA-N Nitric acid Chemical compound O[N+]([O-])=O GRYLNZFGIOXLOG-UHFFFAOYSA-N 0.000 description 1
- 239000004153 Potassium bromate Substances 0.000 description 1
- KEAYESYHFKHZAL-UHFFFAOYSA-N Sodium Chemical compound [Na] KEAYESYHFKHZAL-UHFFFAOYSA-N 0.000 description 1
- 239000005708 Sodium hypochlorite Substances 0.000 description 1
- FHKPLLOSJHHKNU-INIZCTEOSA-N [(3S)-3-[8-(1-ethyl-5-methylpyrazol-4-yl)-9-methylpurin-6-yl]oxypyrrolidin-1-yl]-(oxan-4-yl)methanone Chemical compound C(C)N1N=CC(=C1C)C=1N(C2=NC=NC(=C2N=1)O[C@@H]1CN(CC1)C(=O)C1CCOCC1)C FHKPLLOSJHHKNU-INIZCTEOSA-N 0.000 description 1
- JAWMENYCRQKKJY-UHFFFAOYSA-N [3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-ylmethyl)-1-oxa-2,8-diazaspiro[4.5]dec-2-en-8-yl]-[2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidin-5-yl]methanone Chemical compound N1N=NC=2CN(CCC=21)CC1=NOC2(C1)CCN(CC2)C(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F JAWMENYCRQKKJY-UHFFFAOYSA-N 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229910001870 ammonium persulfate Inorganic materials 0.000 description 1
- 150000003863 ammonium salts Chemical class 0.000 description 1
- 125000005427 anthranyl group Chemical group 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 125000006267 biphenyl group Chemical group 0.000 description 1
- GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 description 1
- 229910052794 bromium Inorganic materials 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 235000013877 carbamide Nutrition 0.000 description 1
- 150000004649 carbonic acid derivatives Chemical class 0.000 description 1
- 239000007809 chemical reaction catalyst Substances 0.000 description 1
- 239000007810 chemical reaction solvent Substances 0.000 description 1
- 229940005991 chloric acid Drugs 0.000 description 1
- 125000000753 cycloalkyl group Chemical group 0.000 description 1
- 125000001995 cyclobutyl group Chemical group [H]C1([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 description 1
- 125000001559 cyclopropyl group Chemical group [H]C1([H])C([H])([H])C1([H])* 0.000 description 1
- 150000004891 diazines Chemical class 0.000 description 1
- GUVUOGQBMYCBQP-UHFFFAOYSA-N dmpu Chemical compound CN1CCCN(C)C1=O GUVUOGQBMYCBQP-UHFFFAOYSA-N 0.000 description 1
- 150000002170 ethers Chemical class 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000004992 fast atom bombardment mass spectroscopy Methods 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 150000008423 fluorobenzenes Chemical class 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- XGZVUEUWXADBQD-UHFFFAOYSA-L lithium carbonate Chemical compound [Li+].[Li+].[O-]C([O-])=O XGZVUEUWXADBQD-UHFFFAOYSA-L 0.000 description 1
- 229910001500 lithium hexafluoroborate Inorganic materials 0.000 description 1
- MHCFAGZWMAWTNR-UHFFFAOYSA-M lithium perchlorate Chemical compound [Li+].[O-]Cl(=O)(=O)=O MHCFAGZWMAWTNR-UHFFFAOYSA-M 0.000 description 1
- 229910001486 lithium perchlorate Inorganic materials 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000008204 material by function Substances 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910044991 metal oxide Inorganic materials 0.000 description 1
- 150000004706 metal oxides Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- SFMJNHNUOVADRW-UHFFFAOYSA-N n-[5-[9-[4-(methanesulfonamido)phenyl]-2-oxobenzo[h][1,6]naphthyridin-1-yl]-2-methylphenyl]prop-2-enamide Chemical compound C1=C(NC(=O)C=C)C(C)=CC=C1N1C(=O)C=CC2=C1C1=CC(C=3C=CC(NS(C)(=O)=O)=CC=3)=CC=C1N=C2 SFMJNHNUOVADRW-UHFFFAOYSA-N 0.000 description 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 125000001624 naphthyl group Chemical group 0.000 description 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- 229910017604 nitric acid Inorganic materials 0.000 description 1
- 150000002825 nitriles Chemical class 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000012285 osmium tetroxide Substances 0.000 description 1
- 229910000489 osmium tetroxide Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- SLIUAWYAILUBJU-UHFFFAOYSA-N pentacene Chemical compound C1=CC=CC2=CC3=CC4=CC5=CC=CC=C5C=C4C=C3C=C21 SLIUAWYAILUBJU-UHFFFAOYSA-N 0.000 description 1
- 125000003538 pentan-3-yl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000004714 phosphonium salts Chemical class 0.000 description 1
- 125000003367 polycyclic group Chemical group 0.000 description 1
- 229920000128 polypyrrole Polymers 0.000 description 1
- 229920000123 polythiophene Polymers 0.000 description 1
- 229940094037 potassium bromate Drugs 0.000 description 1
- 235000019396 potassium bromate Nutrition 0.000 description 1
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 1
- VKJKEPKFPUWCAS-UHFFFAOYSA-M potassium chlorate Chemical compound [K+].[O-]Cl(=O)=O VKJKEPKFPUWCAS-UHFFFAOYSA-M 0.000 description 1
- 239000011698 potassium fluoride Substances 0.000 description 1
- NTTOTNSKUYCDAV-UHFFFAOYSA-N potassium hydride Chemical compound [KH] NTTOTNSKUYCDAV-UHFFFAOYSA-N 0.000 description 1
- 229910000105 potassium hydride Inorganic materials 0.000 description 1
- 239000012286 potassium permanganate Substances 0.000 description 1
- USHAGKDGDHPEEY-UHFFFAOYSA-L potassium persulfate Chemical compound [K+].[K+].[O-]S(=O)(=O)OOS([O-])(=O)=O USHAGKDGDHPEEY-UHFFFAOYSA-L 0.000 description 1
- LPNYRYFBWFDTMA-UHFFFAOYSA-N potassium tert-butoxide Chemical compound [K+].CC(C)(C)[O-] LPNYRYFBWFDTMA-UHFFFAOYSA-N 0.000 description 1
- VBKNTGMWIPUCRF-UHFFFAOYSA-M potassium;fluoride;hydrofluoride Chemical class F.[F-].[K+] VBKNTGMWIPUCRF-UHFFFAOYSA-M 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 125000003548 sec-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- XUXNAKZDHHEHPC-UHFFFAOYSA-M sodium bromate Chemical compound [Na+].[O-]Br(=O)=O XUXNAKZDHHEHPC-UHFFFAOYSA-M 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 1
- 239000012312 sodium hydride Substances 0.000 description 1
- SUKJFIGYRHOWBL-UHFFFAOYSA-N sodium hypochlorite Chemical compound [Na+].Cl[O-] SUKJFIGYRHOWBL-UHFFFAOYSA-N 0.000 description 1
- CHQMHPLRPQMAMX-UHFFFAOYSA-L sodium persulfate Substances [Na+].[Na+].[O-]S(=O)(=O)OOS([O-])(=O)=O CHQMHPLRPQMAMX-UHFFFAOYSA-L 0.000 description 1
- KVCGISUBCHHTDD-UHFFFAOYSA-M sodium;4-methylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1 KVCGISUBCHHTDD-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- UGNWTBMOAKPKBL-UHFFFAOYSA-N tetrachloro-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(Cl)=C(Cl)C1=O UGNWTBMOAKPKBL-UHFFFAOYSA-N 0.000 description 1
- HWCKGOZZJDHMNC-UHFFFAOYSA-M tetraethylammonium bromide Chemical compound [Br-].CC[N+](CC)(CC)CC HWCKGOZZJDHMNC-UHFFFAOYSA-M 0.000 description 1
- YMBCJWGVCUEGHA-UHFFFAOYSA-M tetraethylammonium chloride Chemical compound [Cl-].CC[N+](CC)(CC)CC YMBCJWGVCUEGHA-UHFFFAOYSA-M 0.000 description 1
- QSUJAUYJBJRLKV-UHFFFAOYSA-M tetraethylazanium;fluoride Chemical compound [F-].CC[N+](CC)(CC)CC QSUJAUYJBJRLKV-UHFFFAOYSA-M 0.000 description 1
- BRKFQVAOMSWFDU-UHFFFAOYSA-M tetraphenylphosphanium;bromide Chemical compound [Br-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 BRKFQVAOMSWFDU-UHFFFAOYSA-M 0.000 description 1
- WAGFXJQAIZNSEQ-UHFFFAOYSA-M tetraphenylphosphonium chloride Chemical compound [Cl-].C1=CC=CC=C1[P+](C=1C=CC=CC=1)(C=1C=CC=CC=1)C1=CC=CC=C1 WAGFXJQAIZNSEQ-UHFFFAOYSA-M 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 150000003672 ureas Chemical class 0.000 description 1
Landscapes
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
【課題】新規な高共役化合物の提供。
【解決手段】式(1)
またはそのベンゼン環をピリジン環に換えた構造で示される高共役化合物。また、それらの前駆体としての複素環式化合物が提供される。該前駆体化合物を酸化させることにより、目的とする高共役化合物を製造することができる。かかる化合物は、有機電界効果型トランジスタ、導電性材料として有用である。
【選択図】なしA novel highly conjugated compound is provided.
SOLUTION: Formula (1)
Alternatively, a highly conjugated compound represented by a structure in which the benzene ring is replaced with a pyridine ring. Also provided are heterocyclic compounds as precursors thereof. The target highly conjugated compound can be produced by oxidizing the precursor compound. Such a compound is useful as an organic field effect transistor or a conductive material.
[Selection figure] None
Description
本発明は、高共役化合物並びにその製造方法に関する。 The present invention relates to a highly conjugated compound and a method for producing the same.
従来、大きなπ電子共役系を有する高共役化合物は、有機電界効果型トランジスタやセンサー等の高機能性材料として、興味が持たれている。このような高共役化合物については、様々な研究が進められており、例えば、フルオロベンゼン類とピロールとを反応させた後、得られた化合物を酸化することによりジアジン類が得られることが報告されている(例えば、非特許文献1、非特許文献2)。 Conventionally, highly conjugated compounds having a large π-electron conjugated system have been of interest as highly functional materials such as organic field effect transistors and sensors. Various studies have been conducted on such highly conjugated compounds. For example, it has been reported that diazines can be obtained by reacting fluorobenzenes with pyrrole and then oxidizing the resulting compound. (For example, Non-Patent Document 1 and Non-Patent Document 2).
高共役化合物(特に高平面性を有するもの)を合成する上で最も問題となるのが、原料や生成物の溶解度の低さである。例えば、有機半導体材料として検討が盛んなペンタセンは非常に溶解性が乏しく、高純度化するために昇華精製が行われており、また所望の純度によっては何度も昇華精製を行う必要があり、非常に非効率的であった。
本発明は上記事情に鑑みてなされたものであり、新規な高共役化合物を提供することを目的とする。また、高純度の高共役化合物を効率よく得るのに有用な前駆体並びに、高共役化合物の製造方法を提供することも目的とする。
The most serious problem in synthesizing highly conjugated compounds (especially those having high planarity) is the low solubility of raw materials and products. For example, pentacene, which is actively studied as an organic semiconductor material, has very poor solubility, and has been subjected to sublimation purification in order to achieve high purity, and depending on the desired purity, sublimation purification needs to be performed many times. It was very inefficient.
The present invention has been made in view of the above circumstances, and an object thereof is to provide a novel highly conjugated compound. It is another object of the present invention to provide a precursor useful for efficiently obtaining a highly pure highly conjugated compound and a method for producing the highly conjugated compound.
上記課題を解決することができた本発明の式(1)、式(2a)又は式(2b)で示されることを特徴とする。 It is represented by the formula (1), the formula (2a), or the formula (2b) of the present invention that can solve the above-mentioned problems.
[式(1)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい脂肪族炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい脂肪族炭化水素基の組を表し、これらのハロゲン化していてもよい脂肪族炭化水素基は互いに結合して環構造を形成してもよい。Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。A1〜A4は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(3)で示される置換基を表す。]
Wherein (1), R 1 ~R 4 are the same or different, represent a hydrogen atom or a halogenated optionally an aliphatic hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of aliphatic hydrocarbon groups which may be halogenated, and these aliphatic hydrocarbon groups which may be halogenated are bonded to each other. Thus, a ring structure may be formed. X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX. A 1 to A 4 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (3). ]
[式(2a)、(2b)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい炭化水素基の組を表し、これらのハロゲン化していてもよい炭化水素基は互いに結合して環構造を形成してもよい。Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。A1〜A3は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(3)で示される置換基を表す。]
[In formulas (2a) and (2b), R 1 to R 4 are the same or different and each represents a hydrogen atom or an optionally halogenated hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of hydrocarbon groups which may be halogenated, and these hydrocarbon groups which may be halogenated are bonded to each other to form a ring structure. May be formed. X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX. A 1 to A 3 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (3). ]
[式(3)中、R5、R6は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。*は結合位置を表す。なお、A1〜A4の複数が式(3)で示される置換基のとき、複数のR5はそれぞれ同一でも異なっていてもよく、複数のR6はそれぞれ同一でも異なっていてもよい。]
[In Formula (3), R 5 and R 6 are the same or different and represent a hydrogen atom or a hydrocarbon group which may be halogenated, and may be bonded to each other to form a ring structure. X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX. * Represents a bonding position. Note that when substituents plurality of A 1 to A 4 is represented by the formula (3), a plurality of R 5 may be the same or different, may be different in each of a plurality of R 6 are the same. ]
前記式(1)で示される化合物としては、R1〜R6を除いた骨格が式(4a)〜(4c)に相当するものが好ましい。 As the compound represented by the formula (1), those in which the skeleton excluding R 1 to R 6 corresponds to the formulas (4a) to (4c) are preferable.
[式(4a)〜(4c)中、**はR1〜R6の結合位置を表す。D1、D2は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6a)で表される置換基を示す。]
[In the formulas (4a) to (4c), ** represents a bonding position of R 1 to R 6 . D 1 and D 2 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6a). ]
[式(6a)中、**はR5、R6の結合位置を表す。*は結合位置を表す。]
[In the formula (6a), ** represents the bonding position of R 5 and R 6 . * Represents a bonding position. ]
また、前記式(2a)又は式(2b)で示される化合物としては、R1〜R6を除いた骨格が式(5a)〜(5c)に相当するものが好ましい。
[式(5a)〜(5c)中、*はR1〜R6の結合位置を示す。D1は、水素原子、フッ素原子、シアノ基、又は、式(6a)で表される置換基を示す。]
As examples of the formula (2a) or a compound represented by the formula (2b), which skeleton excluding the R 1 to R 6 corresponds to Formula (5a) ~ (5c) are preferred.
[In formulas (5a) to (5c), * represents a bonding position of R 1 to R 6 . D 1 represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6a). ]
前記式中、R1とR2、R3とR4、又はR5とR6が形成する環構造は、式(7a)又は式(7b)で示されるものが好ましい。 In the above formula, the ring structure formed by R 1 and R 2 , R 3 and R 4 , or R 5 and R 6 is preferably the one represented by the formula (7a) or the formula (7b).
[式(7a)、(7b)中、*は結合位置を示す。]
[In formulas (7a) and (7b), * indicates a bonding position. ]
本発明の高共役化合物前駆体は、式(8)、式(9a)、又は式(9b)で示されることを特徴とする。 The highly conjugated compound precursor of the present invention is represented by the formula (8), the formula (9a), or the formula (9b).
[式(8)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい脂肪族炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい脂肪族炭化水素基の組を表し、これらのハロゲン化していてもよい脂肪族炭化水素基は互いに結合して環構造を形成してもよい。F1〜F4は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6)で示される置換基を表す。]
[In Formula (8), R < 1 > -R < 4 > is the same or different, and represents the aliphatic hydrocarbon group which may be a hydrogen atom or halogenated. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of aliphatic hydrocarbon groups which may be halogenated, and these aliphatic hydrocarbon groups which may be halogenated are bonded to each other. Thus, a ring structure may be formed. F 1 to F 4 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6). ]
[式(9a)、(9b)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい炭化水素基の組を表し、これらのハロゲン化していてもよい炭化水素基は互いに結合して環構造を形成してもよい。F1〜F3は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6)で示される置換基を表す。]
[In the formulas (9a) and (9b), R 1 to R 4 are the same or different and each represents a hydrogen atom or an optionally halogenated hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of hydrocarbon groups which may be halogenated, and these hydrocarbon groups which may be halogenated are bonded to each other to form a ring structure. May be formed. F 1 to F 3 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6). ]
[式(6)中、R5、R6は水素原子又はハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。*は結合位置を表す。なお、F1〜F4の複数が式(6)で示される置換基のとき、複数のR5はそれぞれ同一でも異なっていてもよく、複数のR6はそれぞれ同一でも異なっていてもよい。]
[In formula (6), R 5 and R 6 represent a hydrogen atom or a hydrocarbon group which may be halogenated, and may be bonded to each other to form a ring structure. * Represents a bonding position. Note that when substituents plurality of F 1 to F 4 are represented by the formula (6), a plurality of R 5 may be the same or different, may be different in each of a plurality of R 6 are the same. ]
本発明の高共役化合物の製造方法は、式(10)又は式(11)で示される化合物と、式(12a)〜(12c)で示される化合物のうち2以上(但し、式(12a)で示される化合物及び式(12b)で示される化合物は必ず含む)とから、式(8)、式(9a)又は式(9b)で示される高共役化合物前駆体を合成した後、該高共役化合物前駆体を酸化させることによって、式(1)、式(2a)又は式(2b)で示される高共役化合物を製造することを特徴とする。 The production method of the highly conjugated compound of the present invention is the compound represented by the formula (10) or the formula (11) and two or more of the compounds represented by the formulas (12a) to (12c) (provided that the formula (12a) A highly conjugated compound precursor represented by formula (8), formula (9a) or formula (9b) is synthesized from the compound represented by formula (12b) and the compound represented by formula (12b). By oxidizing the precursor, a highly conjugated compound represented by formula (1), formula (2a) or formula (2b) is produced.
[式(10)、(11)中、E1〜E6は、同一又は異なって、水素原子、フッ素原子、塩素原子、又は、シアノ基を表す。]
[In the formulas (10) and (11), E 1 to E 6 are the same or different and each represents a hydrogen atom, a fluorine atom, a chlorine atom, or a cyano group. ]
[式(12a)〜(12c)中、R1〜R6は水素原子、同一又は異なって、ハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。]
[In the formulas (12a) to (12c), R 1 to R 6 are the same or different and represent a hydrocarbon group which may be halogenated and may be bonded to each other to form a ring structure. Good. ]
また、前記製造方法においては、高共役化合物前駆体を精製した後、該高共役化合物前駆体を酸化させる態様が好ましい。 Moreover, in the said manufacturing method, after refine | purifying a highly conjugated compound precursor, the aspect which oxidizes this highly conjugated compound precursor is preferable.
本発明によれば、新規な高共役化合物が得られる。また、本発明の製造方法によれば、より高純度の高共役化合物を容易に製造することができる。 According to the present invention, a novel highly conjugated compound is obtained. Moreover, according to the production method of the present invention, a highly conjugated compound having a higher purity can be easily produced.
<高共役化合物>
本発明の高共役化合物について説明する。本発明の高共役化合物は、式(1)、式(2a)又は式(2b)で示されることを特徴とする。すなわち、本発明の高共役化合物は、ベンゼン又はピリジンを基本骨格とし、この基本骨格に対して互いにオルト位に位置するように2つのピロリル基が付加されて、これらのピロリル基が環化された構造を有しており、2つのピロリル基の少なくとも一方が3位、4位に置換基を有することを必須の要件とする。
<Highly conjugated compounds>
The highly conjugated compound of the present invention will be described. The highly conjugated compound of the present invention is represented by the formula (1), the formula (2a) or the formula (2b). That is, the highly conjugated compound of the present invention has benzene or pyridine as a basic skeleton, and two pyrrolyl groups are added so as to be located at ortho positions relative to each other, and these pyrrolyl groups are cyclized. It has a structure, and it is an essential requirement that at least one of the two pyrrolyl groups has a substituent at the 3-position and the 4-position.
このように、本発明の高共役化合物では、2つのピロリル基が付加され、これらが環化されていることで、π電子共役系が拡張されてバンドギャップが小さくなる。また、ピロリル基が2つの置換基を有することで、高共役化合物の溶解度が向上し易くなり、精製負荷を軽減できる。さらに置換基によっては、高共役化合物のπ電子共役系をさらに拡張することができ、LUMOを低下させることができる。 Thus, in the highly conjugated compound of the present invention, two pyrrolyl groups are added and these are cyclized, so that the π-electron conjugated system is expanded and the band gap is reduced. In addition, since the pyrrolyl group has two substituents, the solubility of the highly conjugated compound is easily improved and the purification load can be reduced. Furthermore, depending on the substituent, the π-electron conjugated system of the highly conjugated compound can be further expanded, and the LUMO can be lowered.
[式(1)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい脂肪族炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい脂肪族炭化水素基の組を表し、これらのハロゲン化していてもよい脂肪族炭化水素基は互いに結合して環構造を形成してもよい。Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。A1〜A4は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(3)で示される置換基を表す。]
Wherein (1), R 1 ~R 4 are the same or different, represent a hydrogen atom or a halogenated optionally an aliphatic hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of aliphatic hydrocarbon groups which may be halogenated, and these aliphatic hydrocarbon groups which may be halogenated are bonded to each other. Thus, a ring structure may be formed. X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX. A 1 to A 4 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (3). ]
[式(2a)、(2b)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい炭化水素基の組を表し、これらのハロゲン化していてもよい炭化水素基は互いに結合して環構造を形成してもよい。Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。A1〜A3は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(3)で示される置換基を表す。]
[In formulas (2a) and (2b), R 1 to R 4 are the same or different and each represents a hydrogen atom or an optionally halogenated hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of hydrocarbon groups which may be halogenated, and these hydrocarbon groups which may be halogenated are bonded to each other to form a ring structure. May be formed. X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX. A 1 to A 3 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (3). ]
[式(3)中、R5、R6は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。*は結合位置を表す。なお、A1〜A4の複数が式(3)で示される置換基のとき、複数のR5はそれぞれ同一でも異なっていてもよく、複数のR6はそれぞれ同一でも異なっていてもよい。]
[In Formula (3), R 5 and R 6 are the same or different and represent a hydrogen atom or a hydrocarbon group which may be halogenated, and may be bonded to each other to form a ring structure. X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX. * Represents a bonding position. Note that when substituents plurality of A 1 to A 4 is represented by the formula (3), a plurality of R 5 may be the same or different, may be different in each of a plurality of R 6 are the same. ]
前記R1〜R6で表されるハロゲン化していてもよい炭化水素基としては、ハロゲン化していてもよい脂肪族炭化水素基(脂肪族炭化水素基及びハロゲン化脂肪族炭化水素基)、ハロゲン化していてもよい芳香族炭化水素基(芳香族炭化水素基及びハロゲン化芳香族炭化水素基)が挙げられる。 Examples of the optionally halogenated hydrocarbon group represented by R 1 to R 6 include an optionally substituted aliphatic hydrocarbon group (aliphatic hydrocarbon group and halogenated aliphatic hydrocarbon group), halogen An aromatic hydrocarbon group (aromatic hydrocarbon group and halogenated aromatic hydrocarbon group) which may be converted to an aromatic hydrocarbon group.
前記脂肪族炭化水素基としては、飽和脂肪族炭化水素基及び不飽和脂肪族炭化水素基のどちらでもよい。具体的には、例えば、メチル基、エチル基、n−プロピル基、n−ブチル基、n−ペンチル基、n−ヘキシル基等の直鎖状脂肪族炭化水素基;1−メチルエチル基(イソプロピル基)、1,1−ジメチルエチル基(tert−ブチル基)、2,2−ジメチルエチル基(sec−ブチル基)、1−メチルプロピル基、2,2−ジメチルプロピル基、1−エチルプロピル基、ブチル基、1−メチルブチル基、2−メチルブチル基、3−メチルブチル基、1−メチルペンチル基等の分枝鎖状脂肪族炭化水素基;シクロプロピル基、シクロブチル基、シクロペンチル基等の環式脂肪族炭化水素基等が挙げられる。
前記ハロゲン化脂肪族炭化水素基としては、例えば、上記の脂肪族炭化水素基が有する水素原子がハロゲン原子により置換されたものが挙げられる。ここで、ハロゲン原子としては、例えば、フッ素原子、塩素原子、臭素原子、ヨウ素原子が挙げられる。
The aliphatic hydrocarbon group may be either a saturated aliphatic hydrocarbon group or an unsaturated aliphatic hydrocarbon group. Specifically, for example, a linear aliphatic hydrocarbon group such as methyl group, ethyl group, n-propyl group, n-butyl group, n-pentyl group, n-hexyl group; 1-methylethyl group (isopropyl Group), 1,1-dimethylethyl group (tert-butyl group), 2,2-dimethylethyl group (sec-butyl group), 1-methylpropyl group, 2,2-dimethylpropyl group, 1-ethylpropyl group Branched aliphatic hydrocarbon groups such as butyl group, 1-methylbutyl group, 2-methylbutyl group, 3-methylbutyl group and 1-methylpentyl group; cyclic fats such as cyclopropyl group, cyclobutyl group and cyclopentyl group Group hydrocarbon group and the like.
Examples of the halogenated aliphatic hydrocarbon group include those in which the hydrogen atom of the aliphatic hydrocarbon group is substituted with a halogen atom. Here, as a halogen atom, a fluorine atom, a chlorine atom, a bromine atom, and an iodine atom are mentioned, for example.
前記芳香族炭化水素基としては、フェニル基、ナフチル基、アントラニル基、ビフェニル基等が挙げられる。
前記ハロゲン化芳香族炭化水素基としては、例えば、上記の芳香族族炭化水素基が有する水素原子がハロゲン原子により置換されたものが挙げられる。ここで、ハロゲン原子としては、上記のものが挙げられる。
Examples of the aromatic hydrocarbon group include a phenyl group, a naphthyl group, an anthranyl group, and a biphenyl group.
Examples of the halogenated aromatic hydrocarbon group include those in which the hydrogen atom of the aromatic hydrocarbon group is substituted with a halogen atom. Here, examples of the halogen atom include those described above.
ここで、R1とR2、R3とR4又はR5とR6が環構造を形成しない場合、前記R1〜R6は炭素数が2以上のものが好ましく、より好ましくは3以上、さらに好ましくは4以上であり、10以下が好ましく、より好ましくは9以下、さらに好ましくは8以下である。また、これらは直鎖状脂肪族炭化水素基であることが好ましい。前記R1〜R6が分岐鎖状脂肪族炭化水素基であれば、高共役化合物の溶解性がより向上する。しかし、高共役化合物を有機半導体等に用いる場合には、脂肪族炭化水素基の分岐により分子間の相互作用(ππスタッキング)が阻害されるおそれがある。 Here, when R 1 and R 2 , R 3 and R 4 or R 5 and R 6 do not form a ring structure, R 1 to R 6 preferably have 2 or more carbon atoms, more preferably 3 or more. More preferably, it is 4 or more, preferably 10 or less, more preferably 9 or less, still more preferably 8 or less. These are preferably straight-chain aliphatic hydrocarbon groups. When R 1 to R 6 are branched aliphatic hydrocarbon groups, the solubility of the highly conjugated compound is further improved. However, when a highly conjugated compound is used for an organic semiconductor or the like, the interaction between molecules (ππ stacking) may be hindered by the branching of the aliphatic hydrocarbon group.
前記R5、R6で表されるハロゲン化脂肪族炭化水素基としては、炭素数が2以上のものが好ましく、より好ましくは3以上、さらに好ましくは4以上であり、10以下が好ましく、より好ましくは9以下、さらに好ましくは8以下である。また、これらは直鎖状のハロゲン化脂肪族炭化水素基であることが好ましい。前記R5、R6が分岐鎖状脂肪族炭化水素基であれば、高共役化合物の溶解性がより向上する。しかし、高共役化合物を有機半導体等に用いる場合には、脂肪族炭化水素基の分岐により分子間の相互作用(ππスタッキング)が阻害されるおそれがある。 The halogenated aliphatic hydrocarbon group represented by R 5 or R 6 preferably has 2 or more carbon atoms, more preferably 3 or more, still more preferably 4 or more, and more preferably 10 or less, more Preferably it is 9 or less, More preferably, it is 8 or less. These are preferably straight-chain halogenated aliphatic hydrocarbon groups. When R 5 and R 6 are branched aliphatic hydrocarbon groups, the solubility of the highly conjugated compound is further improved. However, when a highly conjugated compound is used for an organic semiconductor or the like, the interaction between molecules (ππ stacking) may be hindered by the branching of the aliphatic hydrocarbon group.
前記R1とR2、R3とR4、又はR5とR6が形成する環構造は、特に限定されるものではなく、単環式でもよいし、橋かけ環状構造等の多環式であってもよい。なお、橋かけ環状炭化水素基には、その内部に不飽和結合を有するものも含まれる。さらに、橋かけ環と単環又は多環とが縮合した構造、或いは橋かけ環同士が縮合した構造も含まれる。これらの中でも、環構造としてはピロリル環と共役し得る環構造や、その前駆体となる環構造が好ましい。このような間構造を形成すれば、高共役化合物のπ電子共役系がさらに拡張され、バンドギャップがより小さくなる。 The ring structure formed by R 1 and R 2 , R 3 and R 4 , or R 5 and R 6 is not particularly limited, and may be monocyclic or polycyclic such as a bridged cyclic structure. It may be. The bridged cyclic hydrocarbon group includes those having an unsaturated bond therein. Furthermore, a structure in which a bridge ring is condensed with a monocyclic ring or a polycycle, or a structure in which bridge rings are condensed with each other is also included. Among these, as the ring structure, a ring structure that can be conjugated with the pyrrolyl ring and a ring structure that is a precursor thereof are preferable. If such an interstructure is formed, the π-electron conjugated system of the highly conjugated compound is further expanded, and the band gap becomes smaller.
前記R1とR2、R3とR4、又はR5とR6が形成する環構造としては、具体的には、例えば式(7a)〜(7f)で示されるものが好ましい。 Specific examples of the ring structure formed by R 1 and R 2 , R 3 and R 4 , or R 5 and R 6 include those represented by formulas (7a) to (7f).
[式(7a)〜(7f)中、*は結合位置を示す。]
[In formulas (7a) to (7f), * indicates a bonding position. ]
上記環構造の中でも、前記R1とR2、R3とR4、又はR5とR6が形成する環構造としては、式(7a)又は式(7b)で示されるものが好適である。なお、式(7b)、(7f)で示される環構造の場合には、熱処理により式(7c)、(7d)で示される環構造に容易に変化させることができる。 Among the ring structures, as the ring structure formed by R 1 and R 2 , R 3 and R 4 , or R 5 and R 6 , those represented by formula (7a) or formula (7b) are preferable. . In the case of the ring structure represented by formulas (7b) and (7f), it can be easily changed to the ring structure represented by formulas (7c) and (7d) by heat treatment.
前記A1〜A6は、水素原子、フッ素原子、シアノ基、又は、式(3)で示される置換基を表すが、これらの中でも、フッ素原子やシアノ基のように電子吸引性を有するものが好ましい。電気吸引性を有する置換基が存在することにより、高共役化合物において電子のエネルギー順位が全体的に低くなり低LUMO(Lowest Unoccupied Molecular Orbital)化が可能となる。 A 1 to A 6 represent a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (3). Among these, those having electron-withdrawing properties such as a fluorine atom and a cyano group Is preferred. Due to the presence of the substituent having electroattractive properties, the energy level of electrons as a whole is lowered in the highly conjugated compound, and the LUMO (Lowest Unoccupied Molecular Orbital) can be reduced.
前記Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。ここで、「近接するX−X間で炭素−炭素結合を形成する」とは、A1〜A6のいずれか(但し、式(1)においては少なくともA1、式(2a)においては少なくともA1又はA3、式(2b)においては少なくともA3)が(3)で示される置換基(ピロリル基又は置換ピロリル基)である場合に、隣接するピロリル基又は置換ピロリル基が環化されていることを指す。 X represents a hydrogen atom, or a carbon-carbon bond is formed between adjacent XX. Here, “form a carbon-carbon bond between adjacent XX” means any one of A 1 to A 6 (provided that at least A 1 in formula (1) and at least in formula (2a) When A 1 or A 3 or at least A 3 in formula (2b) is a substituent represented by (3) (pyrrolyl group or substituted pyrrolyl group), the adjacent pyrrolyl group or substituted pyrrolyl group is cyclized. It points to that.
すなわち、前記式(1)において、近接するX−X間で炭素−炭素結合を形成している態様としては、R1〜R6を除いた骨格が式(4a)〜(4k)に相当するものが挙げられる。 That is, in the formula (1), as an aspect in which a carbon-carbon bond is formed between adjacent XX, a skeleton excluding R 1 to R 6 corresponds to the formulas (4a) to (4k). Things.
[式(4a)〜(4k)中、**はR1〜R6の結合位置を表す。D1〜D4は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6a)で表される置換基を示す。]
[In the formulas (4a) to (4k), ** represents a bonding position of R 1 to R 6 . D 1 to D 4 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6a). ]
[式(6a)中、**はR5、R6の結合位置を表す。*は結合位置を表す。]
[In the formula (6a), ** represents the bonding position of R 5 and R 6 . * Represents a bonding position. ]
これらの中でも、前記式(1)で示される化合物としては、R1〜R6を除いた骨格が式(4a)〜(4c)に相当するものが好ましい。 Among these, as the compound represented by the formula (1), those in which the skeleton excluding R 1 to R 6 corresponds to the formulas (4a) to (4c) are preferable.
また、前記式(2a)又は(2b)において、近接するX−X間で炭素−炭素結合を形成している態様としては、R1〜R6を除いた骨格が式(5a)〜(5i)に相当するものが挙げられる。 In the formula (2a) or (2b), as an aspect in which a carbon-carbon bond is formed between adjacent XX, the skeleton excluding R 1 to R 6 is represented by the formulas (5a) to (5i). ).
[式(5a)〜(5i)中、**はR1〜R6の結合位置を示す。D1〜D3は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6a)で表される置換基を示す。]
[In the formulas (5a) to (5i), ** represents the bonding position of R 1 to R 6 . D 1 to D 3 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6a). ]
これらの中でも、前記式(2a)又は式(2b)で示される化合物としては、R1〜R5を除いた骨格が式(5a)〜(5c)に相当するものが好ましい。 Among these, as the compound represented by the formula (2a) or the formula (2b), those in which the skeleton excluding R 1 to R 5 corresponds to the formulas (5a) to (5c) are preferable.
<高共役化合物前駆体>
次に、本発明の高共役化合物前駆体について説明する。本発明の高共役化合物前駆体は、式(8)、式(9a)又は式(9b)で示されることを特徴とする。すわなち、本発明の高共役化合物前駆体は、ベンゼン又はピリジンを基本骨格とし、この基本骨格に対して互いにオルト位に位置するように2つのピロリル基が付加されて、2つのピロリル基の少なくとも一方が3位、4位に置換基を有することを必須要件とする。このような構成を有する高共役化合物前駆体は、酸化することにより容易に上記高共役化合物を形成し得る。また、当該高共役化合物前駆体は、隣接するピロリル基が環化されていないため、溶解度が高い。そのため、溶媒を用いた精製を行うことができるため容易に精製ができる。従って、より高純度の高共役化合物を容易に得ることができる。
<High conjugated compound precursor>
Next, the highly conjugated compound precursor of the present invention will be described. The highly conjugated compound precursor of the present invention is represented by the formula (8), the formula (9a) or the formula (9b). That is, the highly conjugated compound precursor of the present invention has benzene or pyridine as a basic skeleton, and two pyrrolyl groups are added to the basic skeleton so as to be located in ortho positions relative to each other. It is an essential requirement that at least one has a substituent at the 3-position and the 4-position. The highly conjugated compound precursor having such a structure can easily form the highly conjugated compound by being oxidized. The highly conjugated compound precursor has high solubility because the adjacent pyrrolyl group is not cyclized. Therefore, since the purification using a solvent can be performed, the purification can be easily performed. Therefore, a highly conjugated compound with higher purity can be easily obtained.
[式(8)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい脂肪族炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい脂肪族炭化水素基の組を表し、これらのハロゲン化していてもよい脂肪族炭化水素基は互いに結合して環構造を形成してもよい。F1〜F4は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6)で示される置換基を表す。]
[In Formula (8), R < 1 > -R < 4 > is the same or different, and represents the aliphatic hydrocarbon group which may be a hydrogen atom or halogenated. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of aliphatic hydrocarbon groups which may be halogenated, and these aliphatic hydrocarbon groups which may be halogenated are bonded to each other. Thus, a ring structure may be formed. F 1 to F 4 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6). ]
[式(9a)、(9b)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい炭化水素基の組を表し、これらのハロゲン化していてもよい炭化水素基は互いに結合して環構造を形成してもよい。F1〜F3は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6)で示される置換基を表す。]
[In the formulas (9a) and (9b), R 1 to R 4 are the same or different and each represents a hydrogen atom or an optionally halogenated hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of hydrocarbon groups which may be halogenated, and these hydrocarbon groups which may be halogenated are bonded to each other to form a ring structure. May be formed. F 1 to F 3 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6). ]
[式(6)中、R5、R6は水素原子又はハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。*は結合位置を表す。なお、F1〜F4の複数が式(6)で示される置換基のとき、複数のR5はそれぞれ同一でも異なっていてもよく、複数のR6はそれぞれ同一でも異なっていてもよい。]
[In formula (6), R 5 and R 6 represent a hydrogen atom or a hydrocarbon group which may be halogenated, and may be bonded to each other to form a ring structure. * Represents a bonding position. Note that when substituents plurality of F 1 to F 4 are represented by the formula (6), a plurality of R 5 may be the same or different, may be different in each of a plurality of R 6 are the same. ]
<高共役化合物の製造方法>
次に、本発明の高共役化合物の製造方法について説明する。
本発明の高共役化合物の製造方法は、式(10)又は式(11)で示される化合物と、式(12a)〜(12c)で示される化合物のうち2以上(但し、式(12a)で示される化合物及び式(12b)で示される化合物は必ず含む)とから、式(8)、式(9a)又は式(9b)で示される高共役化合物前駆体を合成した後、該高共役化合物前駆体を酸化させることによって、式(1)、式(2a)又は式(2b)で示される高共役化合物を製造することを特徴とする。
<Method for producing highly conjugated compound>
Next, the manufacturing method of the highly conjugated compound of this invention is demonstrated.
The production method of the highly conjugated compound of the present invention is the compound represented by the formula (10) or the formula (11) and two or more of the compounds represented by the formulas (12a) to (12c) (provided that the formula (12a) A highly conjugated compound precursor represented by formula (8), formula (9a) or formula (9b) is synthesized from the compound represented by formula (12b) and the compound represented by formula (12b). By oxidizing the precursor, a highly conjugated compound represented by formula (1), formula (2a) or formula (2b) is produced.
以下、工程ごとに製造方法を説明する。
本発明の製造方法では、まず、式(10)又は式(11)で示される化合物と、式(12a)〜(12c)で示される化合物のうち2以上(但し、式(12a)で示される化合物及び式(12b)で示される化合物は必ず含む)とから、式(8)、式(9a)又は式(9b)で示される高共役化合物前駆体を合成する。
Hereinafter, a manufacturing method is demonstrated for every process.
In the production method of the present invention, first, a compound represented by the formula (10) or the formula (11) and two or more of the compounds represented by the formulas (12a) to (12c) (however, represented by the formula (12a)). From the compound and the compound represented by the formula (12b), a highly conjugated compound precursor represented by the formula (8), the formula (9a) or the formula (9b) is synthesized.
[式(10)、(11)中、E1〜E6は、水素原子、フッ素原子、塩素原子、又は、シアノ基を表す。]
[In the formulas (10) and (11), E 1 to E 6 represent a hydrogen atom, a fluorine atom, a chlorine atom, or a cyano group. ]
[式(12a)〜(12c)中、R1〜R6は水素原子、ハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。]
[In formulas (12a) to (12c), R 1 to R 6 represent a hydrogen atom or a hydrocarbon group which may be halogenated, and may be bonded to each other to form a ring structure. ]
式(10)又は式(11)で示される化合物と、式(12a)〜(12c)で示される化合物とを反応させる方法は、特に限定されず、これらを混合し、加熱、撹拌することにより行うことができる。反応温度及び反応時間は適宜調整すればよい。 The method for reacting the compound represented by the formula (10) or the formula (11) and the compound represented by the formulas (12a) to (12c) is not particularly limited, and these are mixed, heated and stirred. It can be carried out. What is necessary is just to adjust reaction temperature and reaction time suitably.
なお、反応溶媒としては、アセトン等のケトン類;ジメチルホルムアミド(DMF)、ジメチルアセトアミド(DMAc)等のアミド類;アセトニトリル等のニトリル類;テトラヒドロフラン(THF)、ジエチルエーテル、ジイソプロピルエーテル等のエーテル類;テトラメチルウレア、ジメチルプロピレンウレア等の尿素類;等を用いることができる。また、反応触媒としては、炭酸セシウム(Cs2CO3)、炭酸カリウム(K2CO3)、炭酸ナトリウム(Na2CO3)、炭酸リチウム(Li2CO3)等の炭酸塩;フッ化カリウム(KF)、フッ化ナトリウム(NaF)等のフッ化物;カリウム−tert−ブトキシド、ノルマルブチルリチウム(n−BuLi)、水素化ナトリウム(NaH)、水素化カリウム(KH)等を用いることができる。 Examples of the reaction solvent include ketones such as acetone; amides such as dimethylformamide (DMF) and dimethylacetamide (DMAc); nitriles such as acetonitrile; ethers such as tetrahydrofuran (THF), diethyl ether and diisopropyl ether; Ureas such as tetramethylurea and dimethylpropyleneurea can be used. As the reaction catalyst, carbonates such as cesium carbonate (Cs 2 CO 3), potassium carbonate (K 2 CO 3), sodium carbonate (Na 2 CO 3), lithium carbonate (Li 2 CO 3); potassium fluoride Fluorides such as (KF) and sodium fluoride (NaF); potassium-tert-butoxide, normal butyl lithium (n-BuLi), sodium hydride (NaH), potassium hydride (KH), and the like can be used.
上記のようにして得られた式(8)、式(9a)又は式(9b)で示される高共役化合物前駆体は、上述したように溶解度が高く容易に精製することができる。そのため、本発明の製造方法では、前記高共役化合物前駆体を精製することが好ましい。高共役化合物前駆体の純度を高めることにより、最終的に得られる高共役化合物の純度も容易に高めることができる。 The highly conjugated compound precursor represented by the formula (8), formula (9a) or formula (9b) obtained as described above has high solubility and can be easily purified as described above. Therefore, in the production method of the present invention, it is preferable to purify the highly conjugated compound precursor. By increasing the purity of the high conjugated compound precursor, the purity of the finally obtained high conjugated compound can also be easily increased.
高共役化合物前駆体の精製方法は特に限定されず、シリカゲルクロマトグラフィー、アルミナカラムクロマトグラフィー、昇華精製、再結晶、晶析等を用いることができる。なお、作業の簡便性から、再結晶、晶析、シリカゲルクロマトグラフィーやアルミナカラムクロマトグラフィーが好ましい。 The purification method of the highly conjugated compound precursor is not particularly limited, and silica gel chromatography, alumina column chromatography, sublimation purification, recrystallization, crystallization, and the like can be used. From the viewpoint of simplicity of work, recrystallization, crystallization, silica gel chromatography, and alumina column chromatography are preferable.
次に、上記で得た前記高共役化合物前駆体を酸化する。高共役化合物前駆体を酸化することにより、該前駆体が有する隣接するピロリル基又は置換ピロリル基が環化されて、式(1)、式(2a)又は式(2b)で示される高共役化合物が得られる。この酸化反応は副生成物が反応しにくい。そのため、高共役化合物前駆体の段階で純度を高めておけば、その純度の低下を極力抑えて高共役化合物を製造することができる。 Next, the high conjugated compound precursor obtained above is oxidized. By oxidizing the highly conjugated compound precursor, the adjacent pyrrolyl group or substituted pyrrolyl group of the precursor is cyclized, and the highly conjugated compound represented by formula (1), formula (2a) or formula (2b) Is obtained. This oxidation reaction is difficult for the by-products to react. Therefore, if the purity is increased at the stage of the highly conjugated compound precursor, a decrease in the purity can be suppressed as much as possible to produce a highly conjugated compound.
高共役化合物前駆体を酸化する方法は、特に限定されず、該前駆体が有する隣接するピロリル基又は置換ピロリル基を環化することができればよい。
酸化反応方法としては、化学的酸化、電解酸化等が挙げられる。化学的酸化を採用する場合、用いる酸化剤としては、例えば、酸素、過酸化水素;テトラクロロ−1,4−ベンゾキノン、2,3−ジクロロ−5,6−ジシアノ−1,4−ベンゾキノン等のキノン類;ヨウ素、臭素、塩素等のハロゲン;塩化鉄(III)、塩化銅(II)等の金属塩化物;二酸化マンガン、二酸化鉛、四酸化オスミウム等の金属酸化物;硝酸、塩素酸等のオキソ酸;塩素酸カリウム、次亜塩素酸ナトリウム、臭素酸ナトリウム、臭素酸カリウム、過マンガン酸カリウム、二クロム酸カリウム、過硫酸ナトリウム、過硫酸カリウム、過硫酸アンモニウム等のオキソ酸塩;等が挙げられる。これら酸化剤の中でも、ハロゲン、金属塩化物が好ましい。酸化剤は、1種のみを用いても、2種以上を併用してもよい。また、化学的酸化を採用する場合、用いる酸化剤に応じてUV照射等を行ってもよい。
The method for oxidizing the highly conjugated compound precursor is not particularly limited as long as the adjacent pyrrolyl group or substituted pyrrolyl group of the precursor can be cyclized.
Examples of the oxidation reaction method include chemical oxidation and electrolytic oxidation. When employing chemical oxidation, examples of the oxidizing agent used include oxygen, hydrogen peroxide; tetrachloro-1,4-benzoquinone, 2,3-dichloro-5,6-dicyano-1,4-benzoquinone, and the like. Quinones; Halogens such as iodine, bromine and chlorine; Metal chlorides such as iron (III) chloride and copper (II) chloride; Metal oxides such as manganese dioxide, lead dioxide and osmium tetroxide; Nitric acid and chloric acid Oxo acid; oxo acid salts such as potassium chlorate, sodium hypochlorite, sodium bromate, potassium bromate, potassium permanganate, potassium dichromate, sodium persulfate, potassium persulfate, ammonium persulfate; It is done. Among these oxidizing agents, halogen and metal chloride are preferable. Only 1 type may be used for an oxidizing agent or it may use 2 or more types together. When chemical oxidation is employed, UV irradiation or the like may be performed depending on the oxidizing agent used.
電解酸化を採用する場合、用いる反応装置について限定は無く、電解酸化によるポリピロールやポリチオフェン等の製造で用いられる反応装置を用いることができる。また、電解質としては、例えば、テトラエチルアンモニウムブロミド、テトラエチルアンモニウムクロリド、テトラエチルアンモニウムフルオリド、テトラエチルアンモニウムテトラフルオロボレート、テトラ−n−ブチルアンモニウムヘキサフルオロホスフェート、テトラ−n−ブチルアンモニウムヘキサフルオロアンチモン等のアンモニム塩;テトラフェニルホスホニウムブロミド、テトラフェニルホスホニウムクロリド等のホスホニウム塩;リチウムパークロレート、リチウムヘキサフルオロボレート等のリチウム塩;ベンゼンスルホン酸カリウム、トルエンスルホン酸ナトリウム等のスルホン酸塩;硫酸、塩酸、トリフルオロ酢酸等の酸等が挙げられる。これら電解質は、単独で用いてもよく、2種以上を併用してもよい。 When employing electrolytic oxidation, there is no limitation on the reaction apparatus used, and a reaction apparatus used in the production of polypyrrole, polythiophene, or the like by electrolytic oxidation can be used. Examples of the electrolyte include ammonium salts such as tetraethylammonium bromide, tetraethylammonium chloride, tetraethylammonium fluoride, tetraethylammonium tetrafluoroborate, tetra-n-butylammonium hexafluorophosphate, and tetra-n-butylammonium hexafluoroantimony. Phosphonium salts such as tetraphenylphosphonium bromide and tetraphenylphosphonium chloride; lithium salts such as lithium perchlorate and lithium hexafluoroborate; sulfonates such as potassium benzenesulfonate and sodium toluenesulfonate; sulfuric acid, hydrochloric acid and trifluoroacetic acid And the like. These electrolytes may be used alone or in combination of two or more.
また、得られた高共役化合物は、必要に応じて精製してもよい。精製方法としては、前記高共役化合物前駆体と同様の方法が挙げられる。 Moreover, you may refine | purify the obtained highly conjugated compound as needed. Examples of the purification method include the same methods as those for the highly conjugated compound precursor.
以下に実施例を挙げて本発明をより具体的に説明するが、本発明は、下記実施例によって限定されるものではなく、前・後記の趣旨に適合しうる範囲で適宜変更して実施することも可能であり、それらはいずれも本発明の技術的範囲に包含される。 The present invention will be described more specifically with reference to the following examples. However, the present invention is not limited to the following examples, and may be appropriately modified and implemented within a range that can meet the purpose described above and below. All of which are within the scope of the present invention.
なお、合成された化合物についての分析には、以下の装置を用いた。
融点;Seiko Instruments社製 型式「EXSTAR6000/TG/DTA6200」
紫外−可視吸収スペクトル;日立ハイテクノロジー社製 型式「U−2810」、日本分光社製 型式「v−570型」
赤外吸収スペクトル;堀場製作所製 型式「FT-720」
NMRスペクトル;日本電子社製 型式「JNM−AL400」、日本電子社製 型式「JNM−EX400」、バリアン・テクノロジーズ社製 型式「マーキュリー2000」
マススペクトル;日本電子社製、型式「JMS−MS 700型」
(MALDI−TOF)マススペクトル;アプライド・バイオシステムズ社製、型式「Voyager−DETM−PRO」
In addition, the following apparatus was used for the analysis about the compound synthesize | combined.
Melting point: Model “EXSTAR6000 / TG / DTA6200” manufactured by Seiko Instruments
Ultraviolet-visible absorption spectrum: model “U-2810” manufactured by Hitachi High-Technologies Corporation, model “v-570 model” manufactured by JASCO Corporation
Infrared absorption spectrum: HORIBA, Ltd. Model “FT-720”
NMR spectrum: “JNM-AL400” manufactured by JEOL Ltd., “JNM-EX400” manufactured by JEOL Ltd., “Mercury 2000” manufactured by Varian Technologies, Inc.
Mass spectrum: manufactured by JEOL Ltd. Model “JMS-MS 700”
(MALDI-TOF) mass spectrum; manufactured by Applied Biosystems, model “Voyager-DE ™ -PRO”
1.前駆体の合成
合成例1−1(2,5−Py−3,6−DF−TPN)
1. Synthesis of Precursor Synthesis Example 1-1 (2,5-Py-3,6-DF-TPN)
滴下ロートと還流冷却器を備えた200mlの3つ口反応容器にテトラフルオロテレフタロニトリル5.00g(24.99mmol)、炭酸セシウム8.14g(24.99mmol)を仕込み、反応容器中を窒素置換した後、アセトン50mlを加えた。
滴下ロートにピロール1.68g(25.04mmol)とアセトン17mlを仕込み、ゆっくりと滴下し、滴下終了後60℃に加熱して24時間加熱した。
続いて、炭酸セシウム12.20g(37.44mmol)を反応容器に加えた後、滴下ロートにピロール1.68g(25.04mmol)とアセトン17mlを仕込み、ゆっくりと滴下し、60℃で引き続き48時間加熱した。
その後、反応溶液を冷却し、濾過して無機塩を除き、エバポレーターを用いて濃縮した。濃縮物にメタノールを100ml加え、10分ほど攪拌した後、さらに水10mlを加えて濾過した。濾物を再度メタノールと水を用いて洗浄し、得た濾物を60℃で真空乾燥することで、式(a1)で表される化合物(以下、「2,5−Py−3,6−DF−TPN」)3.66g(12.44mmol、テトラフルオロテレフタロニトリルからの収率50mol%)を得た。
A 200 ml three-necked reaction vessel equipped with a dropping funnel and a reflux condenser was charged with 5.00 g (24.99 mmol) of tetrafluoroterephthalonitrile and 8.14 g (24.99 mmol) of cesium carbonate, and the inside of the reaction vessel was purged with nitrogen. After that, 50 ml of acetone was added.
A dropping funnel was charged with 1.68 g (25.04 mmol) of pyrrole and 17 ml of acetone, slowly dropped, heated to 60 ° C. and heated for 24 hours after completion of the dropping.
Subsequently, 12.20 g (37.44 mmol) of cesium carbonate was added to the reaction vessel, and then 1.68 g (25.04 mmol) of pyrrole and 17 ml of acetone were charged into the dropping funnel and slowly dropped, followed by 48 hours at 60 ° C. Heated.
Thereafter, the reaction solution was cooled, filtered to remove inorganic salts, and concentrated using an evaporator. After adding 100 ml of methanol to the concentrate and stirring for about 10 minutes, 10 ml of water was further added and filtered. The residue was washed again with methanol and water, and the obtained residue was vacuum-dried at 60 ° C., whereby a compound represented by the formula (a1) (hereinafter, “2,5-Py-3,6- DF-TPN ") 3.66 g (12.44 mmol, yield 50 mol% from tetrafluoroterephthalonitrile) was obtained.
得られた2,5−Py−3,6−DF−TPNの分析データは、以下のとおりである。
1H−NMR((CD3)2CO,400MHz):δ=6.46−6.47(m,4H), 7.20−7.22(m,4H).
19F−NMR((CD3)2CO,400MHz)(ヘキサフルオロベンゼン基準):δ=45.80(s,2F)
The analytical data of the obtained 2,5-Py-3,6-DF-TPN are as follows.
1 H-NMR ((CD 3 ) 2 CO, 400 MHz): δ = 6.46-6.47 (m, 4H), 7.20-7.22 (m, 4H).
19 F-NMR ((CD 3 ) 2 CO, 400 MHz) (hexafluorobenzene standard): δ = 45.80 (s, 2F)
合成例1−2(2,5−Py−3,6−TFII−TPN) Synthesis Example 1-2 (2,5-Py-3,6-TFII-TPN)
30ml2つ口反応容器にテトラフルオロイソインドール0.67g(3.54mmol)を仕込み窒素置換した後、テトラヒドロフラン(以下、「THF」)8.2mlを加えてから−78℃まで冷却した。冷却後、n−BuLi/n−ヘキサン溶液2.3ml(n−BuLi含有量3.82mmol)をシリンジでゆっくり加えてそのまま1時間攪拌した。
別の50ml2つ口反応容器に2,5−Py−3,6−DF−TPNを0.5g(1.70mmol)量りとり窒素置換した後、THF14mlを加えて溶解させ、同じく−78℃まで冷却した。
先に調製したテトラフルオロイソインドール溶液をシリンジで抜き取り、後で調整した反応溶液にゆっくりと加えた。
加え終わった後冷却下1時間攪拌してから、冷却用バスを外して12時間攪拌した。
その後、反応溶液に酢酸エチルを加え、更にヘキサンを加えて反応生成物を析出させ濾過した。濾物を、更に酢酸エチル/ヘキサンで再結晶することで、式(8−1)で表される化合物(以下、「2,5−Py−3,6−TFII−TPN」)を0.50g(0.79mmol、2,5−Py−3,6−DF−TPNからの収率47mol%)得た。
A 30 ml two-necked reaction vessel was charged with 0.67 g (3.54 mmol) of tetrafluoroisoindole and purged with nitrogen. Then, 8.2 ml of tetrahydrofuran (hereinafter, “THF”) was added, and then cooled to −78 ° C. After cooling, 2.3 ml of n-BuLi / n-hexane solution (n-BuLi content 3.82 mmol) was slowly added with a syringe and stirred as it was for 1 hour.
In a separate 50 ml two-necked reaction vessel, 0.5 g (1.70 mmol) of 2,5-Py-3,6-DF-TPN was weighed and purged with nitrogen, then 14 ml of THF was added and dissolved, and cooled to -78 ° C. did.
The previously prepared tetrafluoroisoindole solution was withdrawn with a syringe and slowly added to the reaction solution prepared later.
After the addition was completed, the mixture was stirred for 1 hour under cooling, and then the cooling bath was removed and the mixture was stirred for 12 hours.
Thereafter, ethyl acetate was added to the reaction solution, and hexane was further added to precipitate the reaction product, followed by filtration. The filtrate was further recrystallized with ethyl acetate / hexane to give 0.50 g of a compound represented by the formula (8-1) (hereinafter, “2,5-Py-3,6-TFII-TPN”). (0.79 mmol, yield of 47 mol% from 2,5-Py-3,6-DF-TPN).
得られた2,5−Py−3,6−TFII−TPNの分析データは、以下のとおりである。
1H−NMR((CD3)2CO:δ=6.21−6.23(m,4H),6.85−6.86(m,4H),7.73(s,4H).
19F−NMR((CD3)2CO,400MHz)(ヘキサフルオロベンゼン基準):δ=−1.69−−1.64(m,4F),13.23−13.27(m,4F).
UV−bis(CHCl3):λmax,365nm
The analytical data of 2,5-Py-3,6-TFII-TPN obtained are as follows.
1 H-NMR ((CD 3 ) 2 CO: δ = 6.21-6.23 (m, 4H), 6.85-6.86 (m, 4H), 7.73 (s, 4H).
19 F-NMR ((CD 3 ) 2 CO, 400 MHz) (hexafluorobenzene standard): δ = −1.69—1.64 (m, 4F), 13.23-13.27 (m, 4F) .
UV-bis (CHCl 3 ): λmax, 365 nm
合成例1−3(2,3,5,6−TFII−TPN) Synthesis Example 1-3 (2,3,5,6-TFII-TPN)
50ml2つ口反応容器にテトラフルオロイソインドール1.85g(9.78mmol)を仕込み窒素置換した後、THF22mlを加えてから−78℃まで冷却した。冷却後、n−BuLi/n−ヘキサン溶液6.2ml(n−BuLi含有量10.11mmol)をシリンジでゆっくり加えてそのまま1時間攪拌した。
別の100ml2つ口反応容器にテトラフルオロテレフタロニトリルを0.92g(4.60mmol)量りとり窒素置換した後、THF30mlを加えて溶解させ、同じく−78℃に冷却した。
先に調製したテトラフルオロイソインドール溶液をシリンジで抜き取り、後で調製した反応溶液にゆっくりと加えた。
加え終わった後、冷却下1時間攪拌してから、冷却用バスを外して12時間攪拌した。
その後、水を加えて反応をクエンチした後、分液ロートへ反応溶液を移し、酢酸エチルを加え、水洗を3回行った。酢酸エチル溶液を芒硝で乾燥、濃縮した後、シリカゲルカラムクロマトグラフィー(酢酸エチル/ヘキサン)で精製することで、式(8−2)で表される化合物(以下、「2,3,5,6−TFII−TPN」)を0.58g(0.66mmol、テトラフルオロイソインドールからの収率27mol%)得た。
A 50 ml two-necked reaction vessel was charged with 1.85 g (9.78 mmol) of tetrafluoroisoindole and purged with nitrogen, and then 22 ml of THF was added and cooled to -78 ° C. After cooling, 6.2 ml (n-BuLi content 10.11 mmol) of n-BuLi / n-hexane solution was slowly added with a syringe and stirred as it was for 1 hour.
In another 100 ml two-necked reaction vessel, 0.92 g (4.60 mmol) of tetrafluoroterephthalonitrile was weighed and purged with nitrogen, and then 30 ml of THF was added and dissolved, and the mixture was cooled to -78 ° C.
The previously prepared tetrafluoroisoindole solution was withdrawn with a syringe and slowly added to the reaction solution prepared later.
After the addition was completed, the mixture was stirred for 1 hour under cooling, and then the cooling bath was removed and the mixture was stirred for 12 hours.
Then, after adding water and quenching reaction, the reaction solution was moved to the separating funnel, ethyl acetate was added, and water washing was performed 3 times. The ethyl acetate solution was dried with mirabilite, concentrated, and purified by silica gel column chromatography (ethyl acetate / hexane) to obtain a compound represented by the formula (8-2) (hereinafter “2, 3, 5, 6”). -TFII-TPN ") was obtained 0.58 g (0.66 mmol, 27 mol% yield from tetrafluoroisoindole).
得られた2,3,5,6−TFII−TPNの分析データは、以下のとおりである。
1H−NMR((CD3)2CO,400MHz):δ=(t,J=1.2Hz,8H).
19F−NMR((CD3)2CO,400MHz)(ヘキサフルオロベンゼン基準):δ=−0.67−−0.69(m,8F),13.57−13.61(m,8F).
UV−bis(CHCl3):λmax,359nm
The analytical data of 2,3,5,6-TFII-TPN obtained are as follows.
1 H-NMR ((CD 3 ) 2 CO, 400 MHz): δ = (t, J = 1.2 Hz, 8H).
19 F-NMR ((CD 3 ) 2 CO, 400 MHz) (hexafluorobenzene standard): δ = −0.67−0.69 (m, 8F), 13.57-13.61 (m, 8F) .
UV-bis (CHCl 3 ): λmax, 359 nm
合成例1−4(2,5−Py−3,6−(n−Pen)Py−TPN) Synthesis Example 1-4 (2,5-Py-3,6- (n-Pen) Py-TPN)
滴下ロートと還流冷却器を備えた50mlの3つ口反応容器に2,5−Py−3,6−DF−TPNを1.00g(3.40mmol)、炭酸セシウム3.32g(10.19mmol)を仕込み、反応容器中を窒素置換した後ジメチルアセトアミド35mlを加えた。
滴下ロートに3,4−ジ−n−ペンチルピロール1.6g(7.72mmol)とジメチルアセトアミド7mlを仕込み、ゆっくりと滴下し、滴下終了後60℃に加熱して12時間加熱した。
その後、反応溶液を冷却し、濾過して無機塩を除いた後、濃縮した。続いて、シリカゲルカラムクロマトグラフィー(酢酸エチル/ヘキサン)により精製し、式(8−3)で表される化合物(以下、「2,5−Py−3,6−(n−Pen)Py−TPN」)を0.92g(1.38mmol、2,5−Py−3,6−DF−TPNからの収率40mol%)得た。
1.00 g (3.40 mmol) of 2,5-Py-3,6-DF-TPN and 3.32 g (10.19 mmol) of cesium carbonate in a 50 ml three-necked reaction vessel equipped with a dropping funnel and a reflux condenser The reaction vessel was purged with nitrogen and 35 ml of dimethylacetamide was added.
A dropping funnel was charged with 1.6 g (7.72 mmol) of 3,4-di-n-pentylpyrrole and 7 ml of dimethylacetamide, slowly dropped, heated to 60 ° C. and heated for 12 hours after completion of the dropping.
Thereafter, the reaction solution was cooled, filtered to remove inorganic salts, and then concentrated. Then, it refine | purifies by silica gel column chromatography (ethyl acetate / hexane), and the compound (henceforth "2,5-Py-3,6- (n-Pen) Py-TPN" represented by Formula (8-3). 0.92 g (1.38 mmol, 40 mol% yield from 2,5-Py-3,6-DF-TPN).
得られた2,5−Py−3,6−(n−Pen)Py−TPNの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=0.88−0.91(m,12H),1.29−1.36(m,16H),1.36−1.52(m,8H),2.33(t,J=3.6Hz,8H)、6.23−6.24(m,4H),6.40(s,4H),6.74−6.75(m,4H).
UV−bis(CHCl3):λmax,412nm
The analysis data of the obtained 2,5-Py-3,6- (n-Pen) Py-TPN are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 0.88-0.91 (m, 12H), 1.29-1.36 (m, 16H), 1.36-1.52 (m, 8H) ), 2.33 (t, J = 3.6 Hz, 8H), 6.23-6.24 (m, 4H), 6.40 (s, 4H), 6.74-6.75 (m, 4H) ).
UV-bis (CHCl 3 ): λmax, 412 nm
合成例1−5(2,5−Py−3,6−BCPy−TPN)
30ml2つ口反応容器にビシクロピロール0.31g(2.13mmol)を仕込み窒素置換した後、THF4mlを加えてから−78℃まで冷却した。冷却後、n−BuLi/n−ヘキサン溶液1.4ml(n−BuLi含有量2.24mmol)をシリンジでゆっくり加えてそのまま1時間攪拌した。
別の50ml2つ口反応容器に2,5−Py−3,6−DF−TPNを0.30g(1.02mmol)量りとり窒素置換した後、THF12mlを加えて溶解させ、同じく−78℃に冷却した。
先に調製したビシクロピロール溶液をシリンジで抜き取り、後で調製した反応溶液にゆっくりと加えた。
加え終わった後、冷却下1時間攪拌してから、冷却用バスを外して12時間攪拌した。
その後、水を加えて反応をクエンチした後、分液ロートへ反応溶液を移し、酢酸エチルを加え、水洗を3回行った。酢酸エチル溶液を芒硝で乾燥、濃縮した後、シリカゲルカラムクロマトグラフィー(酢酸エチル/ヘキサン)で精製、クロロホルムで再結晶することで、式(8−4)で表される化合物(以下、「2,5−Py−3,6−BCPy−TPN」)を0.16g(0.29mmol、2,5−Py−3,6−DF−TPNからの収率29mol%)得た。
A 30 ml two-necked reaction vessel was charged with 0.31 g (2.13 mmol) of bicyclopyrrole and purged with nitrogen, and then 4 ml of THF was added and cooled to -78 ° C. After cooling, 1.4 ml of n-BuLi / n-hexane solution (content of n-BuLi 2.24 mmol) was slowly added with a syringe and stirred as it was for 1 hour.
In a separate 50 ml two-necked reaction vessel, 0.30 g (1.02 mmol) of 2,5-Py-3,6-DF-TPN was weighed and purged with nitrogen, then 12 ml of THF was added and dissolved, and cooled to -78 ° C. did.
The previously prepared bicyclopyrrole solution was withdrawn with a syringe and slowly added to the reaction solution prepared later.
After the addition was completed, the mixture was stirred for 1 hour under cooling, and then the cooling bath was removed and the mixture was stirred for 12 hours.
Then, after adding water and quenching reaction, the reaction solution was moved to the separating funnel, ethyl acetate was added, and water washing was performed 3 times. The ethyl acetate solution was dried with mirabilite and concentrated, then purified by silica gel column chromatography (ethyl acetate / hexane), and recrystallized with chloroform to obtain a compound represented by the formula (8-4) (hereinafter, “2, 5-Py-3,6-BCPy-TPN ") was obtained 0.16 g (0.29 mmol, 29 mol% yield from 2,5-Py-3,6-DF-TPN).
得られた2,5−Py−3,6−BCPy−TPNの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.45−1.54(m,8H),3.71(s,4H),6.12(s,4H),6.24−6.25(m,4H),6.41(dd,J=3.2、4.8Hz,4H),6.47−6.48(m,4H).
UV−bis(CHCl3):λmax,415nm
The analytical data of the obtained 2,5-Py-3,6-BCPy-TPN are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.45-1.54 (m, 8H), 3.71 (s, 4H), 6.12 (s, 4H), 6.24-6. 25 (m, 4H), 6.41 (dd, J = 3.2, 4.8 Hz, 4H), 6.47-6.48 (m, 4H).
UV-bis (CHCl 3 ): λmax, 415 nm
合成例1−6(2,3,4,5−BCPy−TPN) Synthesis Example 1-6 (2,3,4,5-BCPy-TPN)
反応容器にビシクロピロール0.587g(4.00mmol)を入れ、窒素置換、遮光し、乾燥ジメチルホルムアミド20.0mlに溶解させた。0℃に冷却してNaHのミネラルオイル分散体0.213g(NaH含有量5.33mmol)を加え30分間攪拌した後、乾燥ジメチルホルムアミド20.0mlに溶解させたテトラフルオロテレフタロニトリル0.200g(1.00mmol)を加え、60℃で2時間攪拌した。室温に戻し、水でクエンチ、クロロホルムで抽出し、水、飽和重層水、飽和食塩水で洗浄した後、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後シリカゲルクロマトグラフィー(50%クロロホルム/ヘキサン溶液,Rf=0.2)で精製し、式(8−5)で表される化合物(以下、「2,3,4,5−BCPy−TPN」)を0.4681g(0.669mmol、収率67mol%)得た。
Bicyclopyrrole 0.587 g (4.00 mmol) was placed in the reaction vessel, purged with nitrogen, protected from light, and dissolved in 20.0 ml of dry dimethylformamide. After cooling to 0 ° C. and adding 0.213 g of NaH mineral oil dispersion (NaH content 5.33 mmol) and stirring for 30 minutes, 0.200 g of tetrafluoroterephthalonitrile dissolved in 20.0 ml of dry dimethylformamide ( 1.00 mmol) was added and the mixture was stirred at 60 ° C. for 2 hours. The mixture was returned to room temperature, quenched with water, extracted with chloroform, washed with water, saturated multilayered water, and saturated brine, dried over dried sodium sulfate, and concentrated under reduced pressure.
Thereafter, the product was purified by silica gel chromatography (50% chloroform / hexane solution, Rf = 0.2), and the compound represented by formula (8-5) (hereinafter, “2,3,4,5-BCPy-TPN”) 0.4681 g (0.669 mmol, yield 67 mol%) was obtained.
得られた2,3,4,5−BCPy−TPNの分析データは、以下のとおりである。
m.p:220−230℃(decomp.)
1H−NMR(CDCl3,400MHz):δ=1.47−1.53(m,16H),3.68(s,8H),6.02(s,8H),6.41−6.43(m,8H,)
13C−NMR(CDCl3,100MHz):δ=27.21,32.86,111.20,112.88,113.17,132.75,135.31,139.09.
UV−vis(CH2Cl2):λmax,nm(logε),427nm(3.9851),291nm(4.4287),229nm,(4.5466).
IR(KBr)vmax/cm-1:1481.06,2233.16,2859.92,2933.20,2954.41,3045.05.
MS(MALDI−TOF)m/z=701.0905
(計算値:精密質量=700.3314,分子量=700.8714)
Anal. calcd for C48H40N6:C,82.26;H,5.75;N,11.99;
Anal. calcd for C48H40N6・0.25CHCl3:C,79.31;H,5.55;N,11.50;
Found:C,79.48;H,5.67;N,11.48;
The analytical data of the obtained 2,3,4,5-BCPy-TPN are as follows.
m. p: 220-230 ° C. (decomp.)
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.47-1.53 (m, 16H), 3.68 (s, 8H), 6.02 (s, 8H), 6.41-6. 43 (m, 8H,)
13 C-NMR (CDCl 3 , 100 MHz): δ = 27.21, 32.86, 111.20, 112.88, 113.17, 132.75, 135.31, 139.09.
UV-vis (CH 2 Cl 2 ): λmax, nm (logε), 427nm (3.9851), 291nm (4.4287), 229nm, (4.5466).
IR (KBr) vmax / cm < -1 >: 1481.06, 2233.16, 2859.92, 2933.20, 2954.41, 3045.05.
MS (MALDI-TOF) m / z = 701.0905
(Calculated value: exact mass = 700.3314, molecular weight = 700.8714)
Anal. calcd for C 48 H 40 N 6 : C, 82.26; H, 5.75; N, 11.99;
Anal. calcd for C 48 H 40 N 6 · 0.25CHCl 3: C, 79.31; H, 5.55; N, 11.50;
Found: C, 79.48; H, 5.67; N, 11.48;
合成例1−7(4,5−Py−3,6−DF−PN) Synthesis Example 1-7 (4,5-Py-3,6-DF-PN)
滴下ロートと還流冷却器を備えた200mlの3つ口反応容器にテトラフルオロフタロニトリル8.01g(40.03mmol)、炭酸セシウム6.51g(19.98mmol)を仕込み、反応容器中を窒素置換した後アセトニトリル80mlを加えた。
滴下ロートにピロール2.68g(39.95mmol)とアセトニトリル25mlを仕込み、ゆっくりと滴下し、滴下終了後60℃に加熱して12時間加熱した。
続いて、炭酸セシウム6.52g(20.01mmol)を反応容器に加えた後、滴下ロートにピロール2.68g(39.95mmol)とアセトニトリル25mlを仕込み、ゆっくりと滴下し、60℃で引き続き24時間加熱した。
その後、反応溶液を冷却し、濾過して無機塩を除き、エバポレーターを用いて濃縮した。濃縮物をシリカゲルカラムクロマトグラフィー(酢酸エチル/ヘキサン)及び再結晶により精製し、式(a2)で表される化合物(以下、「4,5−Py−3,6−DF−PN」)を3.29g(11.18mmol、テトラフルオロテレフタロニトリルからの収率28mol%)得た。
A 200 ml three-necked reaction vessel equipped with a dropping funnel and a reflux condenser was charged with 8.01 g (40.03 mmol) of tetrafluorophthalonitrile and 6.51 g (19.98 mmol) of cesium carbonate, and the reaction vessel was purged with nitrogen. Thereafter, 80 ml of acetonitrile was added.
A dropping funnel was charged with 2.68 g (39.95 mmol) of pyrrole and 25 ml of acetonitrile, slowly dropped, heated to 60 ° C. after the completion of dropping, and heated for 12 hours.
Subsequently, 6.52 g (20.01 mmol) of cesium carbonate was added to the reaction vessel, and then 2.68 g (39.95 mmol) of pyrrole and 25 ml of acetonitrile were charged into the dropping funnel, and slowly dropped, and continued at 60 ° C. for 24 hours. Heated.
Thereafter, the reaction solution was cooled, filtered to remove inorganic salts, and concentrated using an evaporator. The concentrate was purified by silica gel column chromatography (ethyl acetate / hexane) and recrystallization, and the compound represented by the formula (a2) (hereinafter, “4,5-Py-3,6-DF-PN”) 3 .29 g (11.18 mmol, 28 mol% yield from tetrafluoroterephthalonitrile) was obtained.
得られた4,5−Py−3,6−DF−PNの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=6.32−6.33(m,4H),6.44−6.46(m,4H).
19F−NMR(CDCl3,400MHz)(ヘキサフルオロベンゼン基準):δ=48.75(s,2F)
The analytical data of the obtained 4,5-Py-3,6-DF-PN are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 6.32-6.33 (m, 4H), 6.44-6.46 (m, 4H).
19 F-NMR (CDCl 3 , 400 MHz) (hexafluorobenzene standard): δ = 48.75 (s, 2F)
合成例1−8(4,5−Py−3,6−TFII−PN) Synthesis Example 1-8 (4,5-Py-3,6-TFII-PN)
滴下ロートと還流冷却器を備えた10mlの2つ口反応容器に4,5−Py−3,6−DF−PNを0.10g(0.34mmol)、炭酸セシウム0.24g(0.74mmol)を仕込み、反応容器中を窒素置換した後ジメチルアセトアミド1.5mlを加えた。
滴下ロートにテトラフルオロイソインドール0.15g(0.79mmol)とジメチルアセトアミド2.1mlを仕込み、ゆっくりと滴下し、滴下終了後60℃に加熱して12時間加熱した。
その後、反応溶液を冷却し、エバポレーターを用いて濃縮した。濃縮後、クロロホルムと水を加え、有機層を洗浄した。さらに有機層は水で2回洗浄した。続いて、シリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)により精製し、式(8−6)で表される化合物(以下、「4,5−Py−3,6−TFII−PN」)を0.07g(0.11mmol、4,5−Py−3,6−DF−PNからの収率33mol%,黄色固体)で得た。
0.10 g (0.34 mmol) of 4,5-Py-3,6-DF-PN and 0.24 g (0.74 mmol) of cesium carbonate in a 10 ml two-necked reaction vessel equipped with a dropping funnel and a reflux condenser The reaction vessel was purged with nitrogen and 1.5 ml of dimethylacetamide was added.
A dropping funnel was charged with 0.15 g (0.79 mmol) of tetrafluoroisoindole and 2.1 ml of dimethylacetamide, slowly dropped, heated to 60 ° C. and heated for 12 hours after completion of the dropping.
Thereafter, the reaction solution was cooled and concentrated using an evaporator. After concentration, chloroform and water were added to wash the organic layer. Further, the organic layer was washed twice with water. Subsequently, the product was purified by silica gel column chromatography (chloroform / hexane), and 0.07 g of a compound represented by the formula (8-6) (hereinafter, “4,5-Py-3,6-TFII-PN”) was obtained. (0.11 mmol, 33 mol% yield from 4,5-Py-3,6-DF-PN, yellow solid).
得られた4,5−Py−3,6−TFII−PNの分析データは、以下のとおりである。
1H−NMR((CD3)2CO,400MHz):δ=5.98−5.99(m,4H),6.35−6.36(m,4H),7.72(t,J=1.2Hz,4H).
19F−NMR((CD3)2CO,400MHz)(ヘキサフルオロベンゼン基準):δ=−1.54−−1.50(m,4F),12.49−12.52(m,4F)
The analysis data of the obtained 4,5-Py-3,6-TFII-PN are as follows.
1 H-NMR ((CD 3 ) 2 CO, 400 MHz): δ = 5.98-5.99 (m, 4H), 6.35-6.36 (m, 4H), 7.72 (t, J = 1.2 Hz, 4H).
19 F-NMR ((CD 3 ) 2 CO, 400 MHz) (hexafluorobenzene standard): δ = −1.54−1.50 (m, 4F), 12.49-12.52 (m, 4F)
合成例1−9(2,3,5,6−BCPy−1,4−DF−BN) Synthesis Example 1-9 (2,3,5,6-BCPy-1,4-DF-BN)
反応容器にビシクロピロール1.165g(8.02mmol)を入れ、窒素置換、遮光し、乾燥ジメチルホルムアミド20.0mlに溶解させ、NaHのミネラルオイル分散体0.5123g(NaH含有量12.81mmol)を加え、15分間攪拌し、ヘキサフルオロベンゼン230μl(2.0mmol)を加え、60℃で3時間攪拌した。室温に戻し、水でクエンチ、クロロホルムで抽出、水、飽和重層水、飽和食塩水で洗浄したのち、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後、エーテルとヘキサンで洗浄することにより、式(8−7)で表される化合物(以下、「2,3,5,6−BCPy−1,4−DF−BN」)を0.995g(1.45mmol、ヘキサフルオロベンゼンからの収率72mol%)得た。
1.165 g (8.02 mmol) of bicyclopyrrole was placed in a reaction vessel, purged with nitrogen, protected from light, dissolved in 20.0 ml of dry dimethylformamide, and 0.5123 g of NaH mineral oil dispersion (NaH content of 12.81 mmol) was added. The mixture was further stirred for 15 minutes, 230 μl (2.0 mmol) of hexafluorobenzene was added, and the mixture was stirred at 60 ° C. for 3 hours. The mixture was returned to room temperature, quenched with water, extracted with chloroform, washed with water, saturated multistory water and saturated brine, dried over dry sodium sulfate, and concentrated under reduced pressure.
Thereafter, 0.995 g of a compound represented by the formula (8-7) (hereinafter, “2,3,5,6-BCPy-1,4-DF-BN”) was washed with ether and hexane. 1.45 mmol, 72 mol% yield from hexafluorobenzene).
得られた2,3,5,6−BCPy−1,4−DF−BNの分析データは、以下のとおりである。
m.p:220−230℃(decomp.)
1H−NMR(CDCl3,400MHz):δ=1.49−1.55(m,16H,),3.69(s,8H),6.00(s,8H),6.43−6.45(m,8H,)
13C−NMR(CDCl3,400MHz):δ=27.49,32.96,57.12,111.62,124.81,131.27,135.60,146.55.;
19F−NMR(CDCl3,400MHz):δ=−134.66
UV−bis(CH2Cl2):λmax,nm(logε),307(4.396),272(4.669).
IR(KBr)vmax/cm-1:1112.73,1498.42,1533.13,1670.05,2863.77,2960.20,3045.05.
MS(MALDI−TOF)m/z=687.2156
(計算値:精密質量=686.3221,分子量=686.8334)
Anal.calcd for C46H40F2N4:C,80.44;H,5.87;F,5.53;N,8.16;
Anal.calcd for C46H40F2N4・0.5H2O:C,79.63;H,5.67;F,5.48;N,8.08;O,1.15
Found:C,79.20;H,5.86;N,8.08.
The analytical data of 2,3,5,6-BCPy-1,4-DF-BN obtained are as follows.
m. p: 220-230 ° C. (decomp.)
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.49-1.55 (m, 16H,), 3.69 (s, 8H), 6.00 (s, 8H), 6.43-6 .45 (m, 8H)
13 C-NMR (CDCl 3 , 400 MHz): δ = 27.49, 32.96, 57.12, 111.62, 124.81, 131.27, 135.60, 146.55. ;
19 F-NMR (CDCl 3 , 400 MHz): δ = −134.66
UV-bis (CH 2 Cl 2 ): λmax, nm (logε), 307 (4.396), 272 (4.669).
IR (KBr) vmax / cm < -1 >: 1112.73, 1498.42, 1533.13, 1670.05, 2863.77, 2960.20, 3045.05.
MS (MALDI-TOF) m / z = 6877.2156
(Calculated value: exact mass = 6866.3221, molecular weight = 6866.8334)
Anal. calcd for C 46 H 40 F 2 N 4: C, 80.44; H, 5.87; F, 5.53; N, 8.16;
Anal. calcd for C 46 H 40 F 2 N 4 · 0.5H 2 O: C, 79.63; H, 5.67; F, 5.48; N, 8.08; O, 1.15
Found: C, 79.20; H, 5.86; N, 8.08.
合成例1−10(2,3,4,5,6−BCPy−F−BN) Synthesis Example 1-10 (2,3,4,5,6-BCPy-F-BN)
反応容器にビシクロピロール377.6mg(2.60mmol)を入れ、遮光し、乾燥ジメチルホルムアミド20.0mlに溶解させ、NaHのミネラルオイル分散体120.4mg(NaH含有量3.01mmol)を加え、15分間攪拌し、ヘキサフルオロベンゼン60.0μl(0.52mmol)を加え、70℃で8時間攪拌した。室温に戻し、水でクエンチ、クロロホルムで抽出、水、飽和重層水、飽和食塩水で洗浄したのち、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後シリカゲルクロマトグラフィー(50% クロロホルム/ヘキサン溶液,Rf=0.5)で精製し、式(8−8)で表される化合物(以下、「2,3,4,5,6−BCPy−F−BN」)を51.5mg(0.063mmol、ヘキサフルオロベンゼンからの収率14mol%)得た。
377.6 mg (2.60 mmol) of bicyclopyrrole was placed in a reaction vessel, protected from light, dissolved in 20.0 ml of dry dimethylformamide, 120.4 mg of NaH mineral oil dispersion (NaH content 3.01 mmol) was added, and 15 After stirring for 6 minutes, 60.0 μl (0.52 mmol) of hexafluorobenzene was added, and the mixture was stirred at 70 ° C. for 8 hours. The mixture was returned to room temperature, quenched with water, extracted with chloroform, washed with water, saturated multistory water and saturated brine, dried over dry sodium sulfate, and concentrated under reduced pressure.
Thereafter, the product was purified by silica gel chromatography (50% chloroform / hexane solution, Rf = 0.5), and the compound represented by the formula (8-8) (hereinafter, “2,3,4,5,6-BCPy-F”). -BN ") was obtained 51.5 mg (0.063 mmol, 14 mol% yield from hexafluorobenzene).
得られた2,3,4,5,6−BCPy−F−BNの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.32−1.51(m,20H),3.51(m,6H),3.67(s,4H)5.54(s,2H),5.61(s,2H),6.02(s,4H),6.31−6.34(m,6H),6.41−6.43(m,4H).
19F−NMR(CDCl3,400MHz):δ=−134.25(s,2H).
MS(FAB)m/z=812
(計算値:精密質量=811.41,分子量=812.03)
The analytical data of 2,3,4,5,6-BCPy-F-BN obtained are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.32-1.51 (m, 20H), 3.51 (m, 6H), 3.67 (s, 4H) 5.54 (s, 2H) ), 5.61 (s, 2H), 6.02 (s, 4H), 6.31-6.34 (m, 6H), 6.41-6.43 (m, 4H).
19 F-NMR (CDCl 3 , 400 MHz): δ = −134.25 (s, 2H).
MS (FAB) m / z = 812
(Calculated value: exact mass = 811.41, molecular weight = 812.03)
合成例1−11(6BCPy−BN) Synthesis Example 1-11 (6BCPy-BN)
反応容器にビシクロピロール873.7mg(6.02mmol)を入れ、窒素置換、遮光し、乾燥ジメチルアセトアミド25.0mlに溶解させ、NaHのミネラルオイル分散体380.2mg(NaH含有量9.51mmol)を加え、15分間攪拌し、ヘキサフルオロベンゼン0.115ml(1.0mmol)を加え、85℃で8時間攪拌した。室温に戻し、水でクエンチ、クロロホルムで抽出、水、飽和重層水、飽和食塩水で洗浄したのち、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後クロロホルムとヘキサンで洗浄することにより、式(8−9)で表される化合物(以下、「6BCPy−BN」)を0.8200mg(0.875mmol、からの収率85mol%)得た。
A reaction vessel was charged with 873.7 mg (6.02 mmol) of bicyclopyrrole, purged with nitrogen, protected from light, dissolved in 25.0 ml of dry dimethylacetamide, and 380.2 mg of NaH mineral oil dispersion (NaH content: 9.51 mmol). The mixture was stirred for 15 minutes, 0.115 ml (1.0 mmol) of hexafluorobenzene was added, and the mixture was stirred at 85 ° C. for 8 hours. The mixture was returned to room temperature, quenched with water, extracted with chloroform, washed with water, saturated multistory water and saturated brine, dried over dry sodium sulfate, and concentrated under reduced pressure.
Thereafter, the resultant was washed with chloroform and hexane to obtain 0.8200 mg (0.875 mmol, 85 mol% yield from 0.86 mmol) of the compound represented by the formula (8-9) (hereinafter “6BCPy-BN”).
得られた6BCPy−BNの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.30−1.32(m,8H),1.42−1.56(m,8H),3.51(s,8H),5.61(s,8H),6.32−6.348(m,8H)
13C−NMR(CDCl3,400MHz):δ=27.71,32.87,110.72,130.80,133.42,135.52.
UV−bis(CH2Cl2):λmax,nm(logε),284(4.704)
IR(KBr)vmax/cm-1:1112.73,1496.49,2861.84,2954.41,3045.05.
MS(MALDI−TOF)m/z=935.4024
(計算値:精密質量=936.4879,分子量=937.2228)
Anal. calcd for C66H60N6:C,84.58;H,6.45;N,8.97;
Anal. calcd for C66H60N6・H2O:C,82.99;H,6.54;N,8.80;O,1.67.
Found:C,83.08;H,6.26;N,9.01.
The analysis data of the obtained 6BCPy-BN are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.30-1.32 (m, 8H), 1.42-1.56 (m, 8H), 3.51 (s, 8H), 5. 61 (s, 8H), 6.32-6.348 (m, 8H)
13 C-NMR (CDCl 3 , 400 MHz): δ = 27.71, 32.87, 110.72, 130.80, 133.42, 135.52.
UV-bis (CH 2 Cl 2 ): λmax, nm (logε), 284 (4.704)
IR (KBr) vmax / cm < -1 >: 1112.73, 1496.49, 2861.84, 2954.41, 3045.05.
MS (MALDI-TOF) m / z = 9355.4024
(Calculated value: exact mass = 936.4879, molecular weight = 937.2228)
Anal. calcd for C 66 H 60 N 6 : C, 84.58; H, 6.45; N, 8.97;
Anal. calcd for C 66 H 60 N 6 · H 2 O: C, 82.99; H, 6.54; N, 8.80; O, 1.67.
Found: C, 83.08; H, 6.26; N, 9.01.
合成例1−12(6(n−Hex)Py−BN) Synthesis Example 1-12 (6 (n-Hex) Py-BN)
反応容器にジ−n−ヘキシルピロール1.33g(5.65mmol)を入れ、窒素置換、遮光し、乾燥ジメチルホルムアミド47mlに溶解させた。0℃に冷却してNaHのミネラルオイル分散体0.38g(NaH含有量9.5mmol)を加え30分間攪拌した後、乾燥ジメチルホルムアミド4.5mlに溶解させたヘキサフルオロベンゼン0.15g(0.81mmol)を加え、60℃で2時間攪拌した。室温に戻し、水でクエンチ、クロロホルムで抽出し、水、飽和重層水、飽和食塩水で洗浄した後、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後シリカゲルクロマトグラフィー(クロロホルム/ヘキサン溶液)で精製し、式(8−10)で表される化合物(以下、「6(n−Hex)Py−BN」))を0.82g(0.55mmol、ヘキサフルオロベンゼンからの収率69mol%)得た。
Di-n-hexylpyrrole (1.33 g, 5.65 mmol) was placed in a reaction vessel, purged with nitrogen, protected from light, and dissolved in 47 ml of dry dimethylformamide. After cooling to 0 ° C. and adding 0.38 g of NaH mineral oil dispersion (NaH content 9.5 mmol) and stirring for 30 minutes, 0.15 g of hexafluorobenzene dissolved in 4.5 ml of dry dimethylformamide (0. 81 mmol) was added, and the mixture was stirred at 60 ° C. for 2 hours. The mixture was returned to room temperature, quenched with water, extracted with chloroform, washed with water, saturated multilayered water, and saturated brine, dried over dried sodium sulfate, and concentrated under reduced pressure.
Thereafter, the resultant was purified by silica gel chromatography (chloroform / hexane solution), and 0.82 g (0.55 mmol) of a compound represented by the formula (8-10) (hereinafter, “6 (n-Hex) Py-BN”)) was obtained. The yield was 69 mol% from hexafluorobenzene).
得られた6(n−Hex)Py−BNの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=0.86−0.90(m,36H),1.24−1.28(m,96H),2.13−2.16(m,24H),5.70(s,12H).
13C−NMR(CDCl3,100MHz):δ=14.18,22.69,25.10,30.36,31.90,117.49,124.53,132.73
Analytical data of the obtained 6 (n-Hex) Py-BN are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 0.86-0.90 (m, 36H), 1.24-1.28 (m, 96H), 2.13-2.16 (m, 24H) ), 5.70 (s, 12H).
13 C-NMR (CDCl 3 , 100 MHz): δ = 14.18, 22.69, 25.10, 30.36, 31.90, 117.49, 124.53, 132.73
合成例1−13(1,2,4,5−BCPy−BN) Synthesis Example 1-13 (1,2,4,5-BCPy-BN)
反応容器にビシクロピロール1.79g(12.33mmol)を入れ、窒素置換、遮光し、乾燥ジメチルホルムアミド116mlに溶解させた。0℃に冷却してNaHのミネラルオイル分散体0.13g(NaH含有量3.25mmol)を加え30分間攪拌した後、乾燥ジメチルホルムアミド12mlに溶解させた1,2,4,5−テトラフルオロベンゼン0.4g(2.67mmol)を加え、60℃で2時間攪拌した。室温に戻し、水でクエンチ、クロロホルムで抽出し、水、飽和重層水、飽和食塩水で洗浄した後、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後シリカゲルクロマトグラフィー(クロロホルム/ヘキサン溶液)で精製し、式(8−11)で表される化合物(以下、「1,2,4,5−BCPy−BN」))を0.72g(1.11mmol、1,2,4,5−テトラフルオロベンゼンからの収率42mol%)得た。
1.79 g (12.33 mmol) of bicyclopyrrole was placed in a reaction vessel, purged with nitrogen, protected from light, and dissolved in 116 ml of dry dimethylformamide. After cooling to 0 ° C. and adding 0.13 g of NaH mineral oil dispersion (NaH content 3.25 mmol) and stirring for 30 minutes, 1,2,4,5-tetrafluorobenzene dissolved in 12 ml of dry dimethylformamide 0.4 g (2.67 mmol) was added, and the mixture was stirred at 60 ° C. for 2 hours. The mixture was returned to room temperature, quenched with water, extracted with chloroform, washed with water, saturated multilayered water, and saturated brine, dried over dried sodium sulfate, and concentrated under reduced pressure.
Thereafter, the product was purified by silica gel chromatography (chloroform / hexane solution), and 0.72 g (1.... Compound represented by formula (8-11) (hereinafter, “1,2,4,5-BCPy-BN”)) 11 mmol, 42 mol% yield from 1,2,4,5-tetrafluorobenzene).
得られた1,2,4,5−BCPy−BNの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.48−1.57(m,16H),3.73(s,8H),6.06(s,8H),6.46−6.47(m,8H),7.32(s,2H)
13C−NMR(CDCl3,100MHz):δ=27.60,33.02,111.12,123.30,131.23,133.66,135.89
The analytical data of 1,2,4,5-BCPy-BN obtained are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.48-1.57 (m, 16H), 3.73 (s, 8H), 6.06 (s, 8H), 6.46-6. 47 (m, 8H), 7.32 (s, 2H)
13 C-NMR (CDCl 3 , 100 MHz): δ = 27.60, 33.02, 111.12, 123.30, 131.23, 133.66, 135.89
合成例1−14(2,4,6−Py−3,5−DF−ピリジン) Synthesis Example 1-14 (2,4,6-Py-3,5-DF-pyridine)
滴下ロートと還流冷却器を備えた200mlの3つ口反応容器にペンタフルオロピリジン5.00g(29.58mmol)、炭酸セシウム34.25g(105.12mmol)を仕込み、反応容器中を窒素置換した後アセトニトリル50mlを加えた。
滴下ロートにピロール6.78g(101.06mmol)とジメチルアセトアミド35mlを仕込み、ゆっくりと滴下し、滴下終了後60℃に加熱して48時間加熱した。
その後、反応溶液を冷却し、濾過して無機塩を除き、エバポレーターを用いて濃縮した。濃縮物にメタノールを100ml加え、10分ほど洗浄のため攪拌した後、濾過した。濾物を再結晶(酢酸エチル/ヘキサン)することで、式(b1)で表される化合物(以下、「2,4,6−Py−3,5−DF−ピリジン」)3.60g(11.60mmol,ペンタフルオロピリジンからの収率39mol%)を得た。
After charging 5.00 g (29.58 mmol) of pentafluoropyridine and 34.25 g (105.12 mmol) of pentafluoropyridine and 34.25 g (105.12 mmol) of cesium carbonate in a 200 ml three-neck reaction vessel equipped with a dropping funnel and a reflux condenser, the reaction vessel was purged with nitrogen. 50 ml of acetonitrile was added.
A dropping funnel was charged with 6.78 g (101.06 mmol) of pyrrole and 35 ml of dimethylacetamide, slowly dropped, heated to 60 ° C. after the dropping, and heated for 48 hours.
Thereafter, the reaction solution was cooled, filtered to remove inorganic salts, and concentrated using an evaporator. 100 ml of methanol was added to the concentrate and stirred for washing for about 10 minutes, followed by filtration. By recrystallizing the filtrate (ethyl acetate / hexane), 3.60 g of a compound represented by the formula (b1) (hereinafter, “2,4,6-Py-3,5-DF-pyridine”) (11 .60 mmol, yield 39 mol% from pentafluoropyridine).
得られた2,4,6−Py−3,5−DF−ピリジンの分析データは、以下のとおりである。
1H−NMR((CD3)2CO,400MHz):δ=6.38−6.39(m,4H),6.44−6.46(m,2H),7.28−7.30(m,2H),7.61−7.62(m,4H).
19F−NMR((CD3)2CO,400MHz)(ヘキサフルオロベンゼン基準):δ=20.86(s,2F).
The analytical data of 2,4,6-Py-3,5-DF-pyridine obtained are as follows.
1 H-NMR ((CD 3 ) 2 CO, 400 MHz): δ = 6.38-6.39 (m, 4H), 6.44-6.46 (m, 2H), 7.28-7.30 (M, 2H), 7.61-7.62 (m, 4H).
19 F-NMR ((CD 3 ) 2 CO, 400 MHz) (hexafluorobenzene standard): δ = 2.86 (s, 2F).
合成例1−15(2,4,6−Py−3,5−(n−Pen)Py−ピリジン) Synthesis Example 1-15 (2,4,6-Py-3,5- (n-Pen) Py-pyridine)
滴下ロートと還流冷却器を備えた100mlの3つ口反応容器に2,4,6−Py−3,5−DF−ピリジンを0.70g(2.26mmol)、3,4−ジペンチルピロール1.08g(5.21mmol)、炭酸セシウム3.72g(11.42mmol)を仕込み、反応容器中を窒素置換した後アセトニトリル33mlを加え、60℃に加熱して48時間加熱した。
その後、反応溶液を冷却し、濾過して無機塩を除き、エバポレーターを用いて濃縮した。濃縮物をシリカゲルクロマトグラフィー(クロロホルム/ヘキサン)により精製することで、式(9−1)で表される化合物(以下、「2,4,6−Py−3,5−(n−Pen)Py−ピリジン」)を0.55g(0.80mmol、2,4,6−Py−3,5−DF−ピリジンからの収率36mol%)得た。
In a 100 ml three-necked reaction vessel equipped with a dropping funnel and a reflux condenser, 0.70 g (2.26 mmol) of 2,4,6-Py-3,5-DF-pyridine and 3,4-dipentylpyrrole 08 g (5.21 mmol) and 3.72 g (11.42 mmol) of cesium carbonate were charged, and the atmosphere in the reaction vessel was replaced with nitrogen, 33 ml of acetonitrile was added, and the mixture was heated to 60 ° C. and heated for 48 hours.
Thereafter, the reaction solution was cooled, filtered to remove inorganic salts, and concentrated using an evaporator. By purifying the concentrate by silica gel chromatography (chloroform / hexane), a compound represented by the formula (9-1) (hereinafter referred to as “2,4,6-Py-3,5- (n-Pen) Py”). -Pyridine ”) was obtained in an amount of 0.55 g (0.80 mmol, 36 mol% yield from 2,4,6-Py-3,5-DF-pyridine).
得られた2,4,6−Py−3,5−(n−Pen)Py−ピリジンの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=0.88(t,J=7.2Hz,12H),1.20−1.31(m、16H),1.37−1.44(m、8H),2.31(t,J=7.2Hz,8H),5.98−5.99(m,2H),6.03−6.04(m,4H),6.11−6.12(m,2H),6.73(t,J=2.4Hz,4H).
Analytical data of the obtained 2,4,6-Py-3,5- (n-Pen) Py-pyridine are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 0.88 (t, J = 7.2 Hz, 12H), 1.20-1.31 (m, 16H), 1.37-1.44 (m 8H), 2.31 (t, J = 7.2 Hz, 8H), 5.98-5.99 (m, 2H), 6.03-6.04 (m, 4H), 6.11-6 .12 (m, 2H), 6.73 (t, J = 2.4 Hz, 4H).
合成例1−16(2,4,6−Py−3,5−BCPy−ピリジン) Synthesis Example 1-16 (2,4,6-Py-3,5-BCPy-pyridine)
30ml2つ口反応容器にビシクロピロール0.52g(3.58mmol)を仕込み窒素置換した後、THF15mlを加えてから−78℃まで冷却した。冷却後、n−BuLi/n−ヘキサン溶液2.4ml(n−BuLi含有量3.82mmol)をシリンジでゆっくり加えてそのまま1時間攪拌した。
別の50ml2つ口反応容器に2,4,6−Py−3,5−DF−ピリジンを0.50g(1.61mmol)量りとり窒素置換した後、THF20ml加えて溶解させ、同じく−78℃まで冷却した。先に調製した溶液をシリンジで抜き取り、2,4,6−Py−3,5−DF−ピリジンの反応溶液にゆっくりと加えた。
加え終わった後冷却下1時間攪拌してから、冷却用バスを外して12時間攪拌した。
その後、水を加えて反応をクエンチした後、分液ロートへ反応溶液を移し、酢酸エチルを加え、水洗を3回行った。酢酸エチル溶液を芒硝で乾燥、濃縮した後、シリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)で精製、クロロホルムで再結晶することで、式(9−2)で表される化合物(以下、「2,4,6−Py−3,5−BCPy−ピリジン」)を0.03g(0.05mmol、2,4,6−Py−3,5−DF−ピリジンからの収率3mol%)得た。
A 30 ml two-necked reaction vessel was charged with 0.52 g (3.58 mmol) of bicyclopyrrole and purged with nitrogen, then 15 ml of THF was added, and then cooled to -78 ° C. After cooling, 2.4 ml of n-BuLi / n-hexane solution (n-BuLi content 3.82 mmol) was slowly added with a syringe and stirred as it was for 1 hour.
In a separate 50 ml two-necked reaction vessel, 0.54 g (1.61 mmol) of 2,4,6-Py-3,5-DF-pyridine was weighed and purged with nitrogen, and then 20 ml of THF was added and dissolved. Cooled down. The previously prepared solution was extracted with a syringe and slowly added to the reaction solution of 2,4,6-Py-3,5-DF-pyridine.
After the addition was completed, the mixture was stirred for 1 hour under cooling, and then the cooling bath was removed and the mixture was stirred for 12 hours.
Then, after adding water and quenching reaction, the reaction solution was moved to the separating funnel, ethyl acetate was added, and water washing was performed 3 times. The ethyl acetate solution was dried and concentrated with sodium sulfate, purified by silica gel column chromatography (chloroform / hexane), and recrystallized with chloroform to obtain a compound represented by the formula (9-2) (hereinafter “2, 4”). , 6-Py-3,5-BCPy-pyridine ") was obtained in an amount of 0.03 g (0.05 mmol, yield of 3 mol% from 2,4,6-Py-3,5-DF-pyridine).
得られた2,4,6−Py−3,5−BCPy−ピリジンの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.43−1.46(m,2H),1.51−1.54(m,2H),3.73(s,2H),5.94−5.95(m,2H),6.00(S,4H),6.06−6.07(m,2H),6.14-6.15(m、4H),6.41−6.43(m,4H),6.69−6.71(m,4H).
Analytical data of the obtained 2,4,6-Py-3,5-BCPy-pyridine are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.4-1.46 (m, 2H), 1.51-1.54 (m, 2H), 3.73 (s, 2H), 5. 94-5.95 (m, 2H), 6.00 (S, 4H), 6.06-6.07 (m, 2H), 6.14-6.15 (m, 4H), 6.41- 6.43 (m, 4H), 6.69-6.71 (m, 4H).
合成例1−17(2,6−Py−3,5−DF−ピリジン) Synthesis Example 1-17 (2,6-Py-3,5-DF-pyridine)
滴下ロートと還流冷却器を備えた200mlの3つ口反応容器に2,3,5,6−テトラフルオロピリジン5.00g(33.10mmol)、炭酸セシウム29.60g(90.85mmol)を仕込み、反応容器中を窒素置換した後アセトニトリル50mlを加えた。
滴下ロートにピロール4.44g(66.18mmol)とジメチルアセトアミド22mlを仕込み、ゆっくりと滴下し、滴下終了後60℃に加熱して48時間加熱した。
反応終了後、反応溶液を冷却し、濾過して無機塩を除き、エバポレーターを用いて濃縮した。濃縮物をシリカゲルカラムクロマトグラフィー(酢酸エチル/ヘキサン)により精製し、さらに再結晶(ヘキサン)により精製することで、式(b2)で表される化合物(以下、「2,6−Py−3,5−DF−ピリジン」)を4.13g(16.84mmol、2,3,5,6−テトラフルオロピリジンからの収率51mol%,白色固体)得た。
A 200 ml three-necked reaction vessel equipped with a dropping funnel and a reflux condenser was charged with 5.00 g (33.10 mmol) of 2,3,5,6-tetrafluoropyridine and 29.60 g (90.85 mmol) of cesium carbonate, After purging the reaction vessel with nitrogen, 50 ml of acetonitrile was added.
The dropping funnel was charged with 4.44 g (66.18 mmol) of pyrrole and 22 ml of dimethylacetamide, slowly dropped, heated to 60 ° C. after the completion of dropping, and heated for 48 hours.
After completion of the reaction, the reaction solution was cooled, filtered to remove inorganic salts, and concentrated using an evaporator. The concentrate was purified by silica gel column chromatography (ethyl acetate / hexane), and further purified by recrystallization (hexane), whereby a compound represented by the formula (b2) (hereinafter, “2,6-Py-3, 5-DF-pyridine ") was obtained (4.13 g, 16.84 mmol, 51 mol% yield from 2,3,5,6-tetrafluoropyridine, white solid).
得られた2,6−Py−3,5−DF−ピリジンの分析データは、以下のとおりである。
1H−NMR((CD3)2CO,400MHz):δ=6.35−6.37(m,4H),7.59(brs,4H).
19F−NMR((CD3)2CO,400MHz)(ヘキサフルオロベンゼン基準):32.28(s,2F)
Analytical data of the obtained 2,6-Py-3,5-DF-pyridine are as follows.
1 H-NMR ((CD 3 ) 2 CO, 400 MHz): δ = 6.35-6.37 (m, 4H), 7.59 (brs, 4H).
19 F-NMR ((CD 3 ) 2 CO, 400 MHz) (hexafluorobenzene standard): 32.28 (s, 2F)
合成例1−18(2,6−Py−3,5−TFII−ピリジン) Synthesis Example 1-18 (2,6-Py-3,5-TFII-pyridine)
滴下ロートと還流冷却器を備えた10mlの2つ口反応容器に2,6−Py−3,5−DF−ピリジンを0.10g(0.41mmol)、炭酸セシウム0.34g(1.04mmol)を仕込み、反応容器中を窒素置換した後ジメチルアセトアミド1.5mlを加えた。
滴下ロートにテトラフルオロイソインドール0.18g(0.95mmol)とジメチルアセトアミド1.7mlを仕込み、ゆっくりと滴下し、滴下終了後60℃に加熱して12時間加熱した。
その後、反応溶液を冷却し、濾過した後濾液をエバポレーターを用いて濃縮した。濃縮後、クロロホルムと水を加え、有機層を洗浄した。さらに有機層は水で2回洗浄した。続いて、シリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)により精製し、式(9−3)で表される化合物(以下、「2,6−Py−3,5−TFII−ピリジン」)を0.09g(0.15mmol,2,6−Py−3,5−DF−ピリジンからの収率38mol%)で得た。
0.10 g (0.41 mmol) of 2,6-Py-3,5-DF-pyridine and 0.34 g (1.04 mmol) of cesium carbonate in a 10 ml two-necked reaction vessel equipped with a dropping funnel and a reflux condenser The reaction vessel was purged with nitrogen and 1.5 ml of dimethylacetamide was added.
A dropping funnel was charged with 0.18 g (0.95 mmol) of tetrafluoroisoindole and 1.7 ml of dimethylacetamide, slowly dropped, heated to 60 ° C. and heated for 12 hours after completion of the dropping.
Thereafter, the reaction solution was cooled and filtered, and then the filtrate was concentrated using an evaporator. After concentration, chloroform and water were added to wash the organic layer. Further, the organic layer was washed twice with water. Subsequently, it was purified by silica gel column chromatography (chloroform / hexane), and 0.09 g of a compound represented by the formula (9-3) (hereinafter, “2,6-Py-3,5-TFII-pyridine”) was obtained. (0.15 mmol, 2,6-Py-3,5-DF-pyridine yield 38 mol%).
合成例1−19(2,3,5,6−BCPy−ピリジン) Synthesis Example 1-19 (2,3,5,6-BCPy-pyridine)
200mlの2つ口反応容器にNaHのミネラルオイル分散体1.02g(NaH含有量25.5mmol)を入れて、反応容器内を窒素置換した後、ジメチルホルムアミド70mlを加えて40℃に加熱した。そこへビシクロピロール1.45g(9.99mmol)を20mlのジメチルホルムアミドに溶解させた溶液を、シリンジを用いてゆっくりと加え10分間撹拌した。
続いて2,3,5,6−テトラフルオロピリジン0.32g(2.12mmol)を10mlのジメチルホルムアミドに溶解させた溶液を、シリンジを用いてゆっくりと反応容器に加えた。
10分間撹拌した後、反応温度を65℃に上げ、4時間反応させた。
その後、反応容器に少量の水を加えて反応をクエンチし、反応溶液を濾過して不溶分を除いた。反応液を一度濃縮した後、クロロホルムを加えて濃縮物を溶解させて、水で3回洗浄した。有機層は無水硫酸ナトリウムを用いて乾燥し、濃縮した後シリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)により精製し、式(9−4)で表される化合物(以下、「2,3,5,6−BCPy−ピリジン」)を1.07g(1.64mmol、2,3,5,6−テトラフルオロピリジンからの収率77mol%)得た。
A 200 ml two-necked reaction vessel was charged with 1.02 g of NaH mineral oil dispersion (NaH content 25.5 mmol), the inside of the reaction vessel was purged with nitrogen, 70 ml of dimethylformamide was added, and the mixture was heated to 40 ° C. A solution prepared by dissolving 1.45 g (9.99 mmol) of bicyclopyrrole in 20 ml of dimethylformamide was slowly added using a syringe and stirred for 10 minutes.
Subsequently, a solution prepared by dissolving 0.32 g (2.12 mmol) of 2,3,5,6-tetrafluoropyridine in 10 ml of dimethylformamide was slowly added to the reaction vessel using a syringe.
After stirring for 10 minutes, the reaction temperature was raised to 65 ° C. and reacted for 4 hours.
Thereafter, a small amount of water was added to the reaction vessel to quench the reaction, and the reaction solution was filtered to remove insoluble matters. After the reaction solution was concentrated once, chloroform was added to dissolve the concentrate, and the mixture was washed 3 times with water. The organic layer was dried over anhydrous sodium sulfate, concentrated and then purified by silica gel column chromatography (chloroform / hexane) to obtain a compound represented by the formula (9-4) (hereinafter “2, 3, 5, 6”). -BCPy-pyridine ") was obtained 1.07 g (1.64 mmol, 77 mol% yield from 2,3,5,6-tetrafluoropyridine).
得られた2,3,5,6−BCPy−ピリジンの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.49−1.63(m,16H),3.66(s,4H),3.83(s,4H),6.24(s,4H),6.30(s,4H),6.44(dd,J=2.8、4.4Hz,4H),6.51(dd,J=2.8、4.4Hz,4H),7.60(s,1H).
Analytical data of the obtained 2,3,5,6-BCPy-pyridine are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.49-1.63 (m, 16H), 3.66 (s, 4H), 3.83 (s, 4H), 6.24 (s, 4H), 6.30 (s, 4H), 6.44 (dd, J = 2.8, 4.4 Hz, 4H), 6.51 (dd, J = 2.8, 4.4 Hz, 4H), 7.60 (s, 1H).
2.高共役化合物の合成
合成例2−1(2,5−Py−3,6−TFII−TPN−OX)
2. Synthesis of High Conjugated Compound Synthesis Example 2-1 (2,5-Py-3,6-TFII-TPN-OX)
100ml反応容器に2,5−Py−3,6−TFII−TPNを0.15g(0.24mmol)、ジクロロメタンを76g量りとった後、攪拌し均一の溶液とした。この反応溶液にヨウ素のジクロロメタン溶液<ヨウ素(I2)0.13g(0.51mmol)をジクロロメタン5gで溶解させた>を撹拌下加えた後、UVランプで光を10時間照射した。
照射後、亜硫酸水素ナトリウム水溶液で反応をクエンチし、反応液を濾過して不溶物を除いた。濾液を水で3回洗浄し、ジクロロメタン層を芒硝により乾燥、エバポレーターにより濃縮した。続いて濃縮物をシリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)により精製し、60℃真空乾燥して、式(1−1)で表される化合物(以下、「2,5−Py−3,6−TFII−TPN−OX」)を0.03g(0.05mmol、収率21mol%)で得た。
得られた2,5−Py−3,6−TFII−TPN−OXの分析データは、以下のとおりである。
UV−bis(CHCl3):λmax,472nm
In a 100 ml reaction vessel, 0.15 g (0.24 mmol) of 2,5-Py-3,6-TFII-TPN and 76 g of dichloromethane were weighed and stirred to obtain a uniform solution. To this reaction solution, a dichloromethane solution of iodine (0.13 g (0.51 mmol) of iodine (I 2 ) dissolved in 5 g of dichloromethane) was added with stirring, and then irradiated with light with a UV lamp for 10 hours.
After irradiation, the reaction was quenched with an aqueous sodium hydrogen sulfite solution, and the reaction solution was filtered to remove insoluble matters. The filtrate was washed with water three times, and the dichloromethane layer was dried with sodium sulfate and concentrated with an evaporator. Subsequently, the concentrate was purified by silica gel column chromatography (chloroform / hexane), vacuum-dried at 60 ° C., and the compound represented by the formula (1-1) (hereinafter “2,5-Py-3,6- TFII-TPN-OX ") was obtained in 0.03 g (0.05 mmol, yield 21 mol%).
The analytical data of the obtained 2,5-Py-3,6-TFII-TPN-OX are as follows.
UV-bis (CHCl 3 ): λmax, 472 nm
合成例2−2(2,5−Py−3,6−(n−Pen)Py−TPN−OX) Synthesis Example 2-2 (2,5-Py-3,6- (n-Pen) Py-TPN-OX)
100ml反応容器に2,5−Py−3,6−(n−Pen)Py−TPNを0.46g(0.69mmol)、ジクロロメタンを5g量りとった後、攪拌し均一の溶液とした。この反応溶液にヨウ素のジクロロメタン溶液<ヨウ素(I2)0.70g(2.76mmol)をジクロロメタン67gで溶解させた>を撹拌下加えた後、UVランプで光を10時間照射した。
照射後、亜硫酸水素ナトリウム水溶液で反応をクエンチし、反応液を濾過して不溶物を除いた。濾液を水で3回洗浄し、ジクロロメタン層を芒硝により乾燥、エバポレーターにより濃縮した。続いて濃縮物をシリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)、再結晶(クロロホルム/メタノール)により精製して、式(1−2)で表される化合物(以下、「2,5−Py−3,6−(n−Pen)Py−TPN−OX」)を0.26g(0.39mmol、収率56mol%)で得た。
In a 100 ml reaction vessel, 0.46 g (0.69 mmol) of 2,5-Py-3,6- (n-Pen) Py-TPN and 5 g of dichloromethane were weighed and stirred to obtain a uniform solution. To this reaction solution, a dichloromethane solution of iodine <0.70 g (2.76 mmol) of iodine (I 2 ) dissolved in 67 g of dichloromethane> was added with stirring, and then irradiated with light from a UV lamp for 10 hours.
After irradiation, the reaction was quenched with an aqueous sodium hydrogen sulfite solution, and the reaction solution was filtered to remove insoluble matters. The filtrate was washed with water three times, and the dichloromethane layer was dried with sodium sulfate and concentrated with an evaporator. Subsequently, the concentrate was purified by silica gel column chromatography (chloroform / hexane) and recrystallization (chloroform / methanol) to obtain a compound represented by the formula (1-2) (hereinafter referred to as “2,5-Py-3, 6- (n-Pen) Py-TPN-OX ") was obtained in 0.26 g (0.39 mmol, yield 56 mol%).
得られた2,5−Py−3,6−(n−Pen)Py−TPN−OXの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=0.92−0.95(m,6H),1.39−1.45(m、8H),1.57−1.61(m,2H),1.67−1.70(m,2H),2.55(t,J=8.0Hz,2H),2.65(t,J=8.0Hz,2H),6.51(dd,J=1.2、3.6Hz,1H),6.65−6.67(m,1H),8.11(s,1H),8.40(dd,J=1.2、3.6Hz,1H).
UV−bis(CHCl3):λmax,510nm
The analysis data of the obtained 2,5-Py-3,6- (n-Pen) Py-TPN-OX are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 0.92-0.95 (m, 6H), 1.39-1.45 (m, 8H), 1.57-1.61 (m, 2H) ), 1.67-1.70 (m, 2H), 2.55 (t, J = 8.0 Hz, 2H), 2.65 (t, J = 8.0 Hz, 2H), 6.51 (dd , J = 1.2, 3.6 Hz, 1H), 6.65-6.67 (m, 1H), 8.11 (s, 1H), 8.40 (dd, J = 1.2, 3.H. 6 Hz, 1 H).
UV-bis (CHCl 3 ): λmax, 510 nm
合成例2−3(2,5−Py−3,6−BCPy−TPN−OX) Synthesis Example 2-3 (2,5-Py-3,6-BCPy-TPN-OX)
100ml反応容器に2,5−Py−3,6−BCPy−TPNを0.15g(0.28mmol)、ジクロロメタンを1.5g量りとった後、攪拌し均一の溶液とした。この反応溶液にヨウ素のジクロロメタン溶液<ヨウ素(I2)0.21g(0.83mmol)をジクロロメタン10gで溶解させた>を撹拌下加えた後、UVランプで光を10時間照射した。
照射後、亜硫酸水素ナトリウム水溶液で反応をクエンチし、反応液を濾過して不溶物を除いた。濾液を水で3回洗浄し、ジクロロメタン層を芒硝により乾燥、エバポレーターにより濃縮した。続いて濃縮物をシリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)、再結晶(クロロホルム/ヘキサン)により精製して、式(1−3)で表される化合物(以下、「2,5−Py−3,6−BCPy−TPN−OX」)を0.07g(0.13mmol、収率46mol%)で得た。
In a 100 ml reaction vessel, 0.15 g (0.28 mmol) of 2,5-Py-3,6-BCPy-TPN and 1.5 g of dichloromethane were weighed and stirred to obtain a uniform solution. To this reaction solution, a dichloromethane solution of iodine <0.21 g (0.83 mmol) of iodine (I 2 ) dissolved in 10 g of dichloromethane> was added with stirring, and then irradiated with light from a UV lamp for 10 hours.
After irradiation, the reaction was quenched with an aqueous sodium hydrogen sulfite solution, and the reaction solution was filtered to remove insoluble matters. The filtrate was washed with water three times, and the dichloromethane layer was dried with sodium sulfate and concentrated with an evaporator. Subsequently, the concentrate was purified by silica gel column chromatography (chloroform / hexane) and recrystallization (chloroform / hexane) to obtain a compound represented by the formula (1-3) (hereinafter referred to as “2,5-Py-3, 6-BCPy-TPN-OX ") was obtained in 0.07 g (0.13 mmol, yield 46 mol%).
得られた2,5−Py−3,6−BCPy−TPN−OXの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.58−1.72(m,8H),3.98−4.00(m,2H),4.21−4.22(m,2H),6.54−6.60(m,2H),6.65(t,J=3.6Hz,2H),8.07(s,2H),8.34(dd,J=1.2、3.6Hz,2H).
UV−bis(CHCl3):λmax,511nm
The analytical data of the obtained 2,5-Py-3,6-BCPy-TPN-OX are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.58-1.72 (m, 8H), 3.98-4.00 (m, 2H), 4.21-4.22 (m, 2H) ), 6.54-6.60 (m, 2H), 6.65 (t, J = 3.6 Hz, 2H), 8.07 (s, 2H), 8.34 (dd, J = 1.2 3.6 Hz, 2H).
UV-bis (CHCl 3 ): λmax, 511 nm
合成例2−4(2,3,4,5−BCPy−TPN−OX) Synthesis Example 2-4 (2,3,4,5-BCPy-TPN-OX)
反応容器に2,3,4,5−BCPy−TPNを351.9mg(0.503mmol)入れ、ジクロロメタン20.0mlに溶解させたのちアセトニトリル30.0mlを加えた。ヨウ素(I2)0.2800g(1.1mmol)を加え、3時間光を当てつづけた。反応後、亜硝酸ナトリウム水溶液でクエンチ、クロロホルムで抽出、水、飽和重層水、飽和食塩水で洗浄したのち、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後シリカゲルクロマトグラフィー(50%クロロホルム/ヘキサン溶液,Rf=0.7)で精製し、少量のトルエンで再結晶することにより、式(1−4)で表される化合物(以下、「2,3,4,5−BCPy−TPN−OX」)を114.8mg(0.165mmol、収率33mol%)得た。
得られた2,3,4,5−BCPy−TPN−OXの分析データは、以下のとおりである。
m.p:220−230℃(decomp.)
1H−NMR(CDCl3,400MHz):δ=1.67−1.74(m,16H),3.95(s,4H),4.29(m,4H),6.54−6.60(m,8H),7.97(s,4H).
13C−NMR(CDCl3,100MHz):δ=26.48,26.51,26.72,26.82,33.13,33.92,34.06,89.24,107.61,115.95,115.95,116.00,118.59,123.73,123.82,126.28,126.33,135.07,135.08,135.25,135.37,135.47,135.55,135.56.
UV−vis(CH2Cl2):λmax,nm(logε),527nm,(4.3671),279nm,(4.8649)
IR(KBr)vmax/cm-1:1236.15,1467.56,2210.02,2863.77,2935.13,3045.05.
MS(MALDI−TOF)m/z=697.1765
(計算値:精密質量=696.3001,分子量=696.8396)
Anal. calcd for C48H36N6:C,82.73;H,5.21;N,12.06;
Anal. calcd for C48H36N6・0.5H2O:C,81.68;H,5.28;N,11.91;
Found:C,81.95;H,5.53;N,11.54.
351.9 mg (0.503 mmol) of 2,3,4,5-BCPy-TPN was placed in a reaction vessel, dissolved in 20.0 ml of dichloromethane, and then 30.0 ml of acetonitrile was added. Iodine (I 2 ) 0.2800 g (1.1 mmol) was added, and the light was kept on for 3 hours. After the reaction, the reaction mixture was quenched with an aqueous sodium nitrite solution, extracted with chloroform, washed with water, saturated multistory water, and saturated brine, dried over dried sodium sulfate, and concentrated under reduced pressure.
Thereafter, the product is purified by silica gel chromatography (50% chloroform / hexane solution, Rf = 0.7) and recrystallized with a small amount of toluene, whereby the compound represented by the formula (1-4) (hereinafter referred to as “2,3”). , 4, 5-BCPy-TPN-OX ") was obtained (114.8 mg, 0.165 mmol, 33 mol% yield).
Analysis data of the obtained 2,3,4,5-BCPy-TPN-OX are as follows.
m. p: 220-230 ° C. (decomp.)
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.67-1.74 (m, 16H), 3.95 (s, 4H), 4.29 (m, 4H), 6.54-6. 60 (m, 8H), 7.97 (s, 4H).
13 C-NMR (CDCl 3 , 100 MHz): δ = 26.48, 26.51, 26.72, 26.82, 33.13, 33.92, 34.06, 89.24, 107.61, 115 .95, 115.95, 116.00, 118.59, 123.73, 123.82, 126.28, 126.33, 135.07, 135.08, 135.25, 135.37, 135.47 , 135.55, 135.56.
UV-vis (CH 2 Cl 2 ): λmax, nm (log ε), 527 nm, (4.3671), 279 nm, (4.8649)
IR (KBr) vmax / cm < -1 >: 1236.35,1467.56,2210.02,286377,293.13,3045.05.
MS (MALDI-TOF) m / z = 697.1765
(Calculated value: exact mass = 696.3001, molecular weight = 696.8396)
Anal. calcd for C 48 H 36 N 6 : C, 82.73; H, 5.21; N, 12.06;
Anal. calcd for C 48 H 36 N 6 · 0.5H 2 O: C, 81.68; H, 5.28; N, 11.91;
Found: C, 81.95; H, 5.53; N, 11.54.
合成例2−5(4,5−Py−3,6−TFII−PN−OX) Synthesis Example 2-5 (4,5-Py-3,6-TFII-PN-OX)
5ml反応容器に4,5−Py−3,6−TFII−PNを0.02g(0.03mmol)、ジクロロメタン1g量りとった後、攪拌し均一の溶液とした。この反応溶液にヨウ素のジクロロメタン溶液<ヨウ素(I2)0.05g(0.20mmol)をジクロロメタン0.6gで溶解させた>を撹拌下加えた後、UVランプで光を10時間照射した。
照射後、亜硫酸水素ナトリウム水溶液で反応をクエンチし、反応液を濾過、濾過残渣を水、クロロホルム、エタノールでかけ洗いし、60℃真空乾燥して、式(1−5)で表される化合物(以下、「4,5−Py−3,6−TFII−PN−OX」)を0.014g(0.02mmol、収率71mol%,茶色固体)で得た。
Into a 5 ml reaction vessel, 0.02 g (0.03 mmol) of 4,5-Py-3,6-TFII-PN and 1 g of dichloromethane were weighed and stirred to obtain a homogeneous solution. To this reaction solution, a dichloromethane solution of iodine (0.05 g (0.20 mmol) of iodine (I 2 ) dissolved in 0.6 g of dichloromethane) was added with stirring, and then irradiated with light from a UV lamp for 10 hours.
After irradiation, the reaction was quenched with an aqueous sodium hydrogen sulfite solution, the reaction solution was filtered, the filtration residue was washed with water, chloroform, and ethanol, dried at 60 ° C. under vacuum, and the compound represented by the formula (1-5) (hereinafter referred to as the formula (1-5)) , “4,5-Py-3,6-TFII-PN-OX”) was obtained in 0.014 g (0.02 mmol, yield 71 mol%, brown solid).
合成例2−6(2,3,5,6−BCPy−1,4−DF−BN−OX) Synthesis Example 2-6 (2,3,5,6-BCPy-1,4-DF-BN-OX)
反応容器に2,3,5,6−BCPy−1,4−DF−BNを995.4mg(1.45mmol)入れ、ジクロロメタン140.0mlに溶解させたのちアセトニトリル100.0mlを加えた。ヨウ素(I2)761.4mg(3.04mmol)を加え、5時間光を当てつづけた。
反応後、亜硝酸ナトリウム水溶液でクエンチ、クロロホルムで抽出、水、飽和重層水、飽和食塩水で洗浄したのち、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。
その後、エーテルとヘキサンで洗浄することにより、式(1−6)で表される化合物(以下、「2,3,5,6−BCPy−1,4−DF−BN−OX」)を267.33mg(0.392mmol、収率27mol%)得た。
得られた2,3,5,6−BCPy−1,4−DF−BN−OXの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.68−1.76(m,16H),3.98(s,4H),4.45−4.50(m,4H),6.60(m,8H),7.62(s,8H).
13C−NMR(CDCl3,400MHz):δ=26.80,26.93,27.03,33.21,34.24,34.39,115.83,121.57,135.79,135.89,136.01,155.59.
19F−NMR(CDCl3,400MHz):δ=−136.06(s,2H).
UV−bis(CH2Cl2):λmax,nm(logε),359(4.424),285(5.015).
IR(KBr)vmax/cm-1:1508.06,2861.84,2931.27,3041.19.
MS(MALDI−TOF)m/z=684.2003
(計算値:精密質量=682.2908,分子量=682.8016)
Anal.calcd for C46H36F2N4:C,80.92;H,5.31;F,5.56;N,8.21.
Anal.calcd for C46H40F2N4・0.25CHCl3:C,77.95;H,5.13;Cl,3.73;F,5.33;N,7.86.
Found:C,77.57;H,5.23;N,7.87.
995.4 mg (1.45 mmol) of 2,3,5,6-BCPy-1,4-DF-BN was placed in a reaction vessel, dissolved in 140.0 ml of dichloromethane, and then 100.0 ml of acetonitrile was added. Iodine (I 2 ) 761.4 mg (3.04 mmol) was added, and the light was kept on for 5 hours.
After the reaction, the reaction mixture was quenched with an aqueous sodium nitrite solution, extracted with chloroform, washed with water, saturated multistory water, and saturated brine, dried over dried sodium sulfate, and concentrated under reduced pressure.
Thereafter, the compound represented by the formula (1-6) (hereinafter, “2,3,5,6-BCPy-1,4-DF-BN-OX”) is obtained by washing with ether and hexane 267. 33 mg (0.392 mmol, yield 27 mol%) was obtained.
The analytical data of 2,3,5,6-BCPy-1,4-DF-BN-OX obtained are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.68-1.76 (m, 16H), 3.98 (s, 4H), 4.45-4.50 (m, 4H), 6. 60 (m, 8H), 7.62 (s, 8H).
13 C-NMR (CDCl 3 , 400 MHz): δ = 26.80, 26.93, 27.03, 33.21, 34.24, 34.39, 115.83, 121.57, 135.79, 135 89, 136.01, 155.59.
19 F-NMR (CDCl 3 , 400 MHz): δ = −136.06 (s, 2H).
UV-bis (CH 2 Cl 2 ): λmax, nm (logε), 359 (4.424), 285 (5.015).
IR (KBr) vmax / cm < -1 >: 1508.06, 2618.84, 2931.27, 3041.19.
MS (MALDI-TOF) m / z = 684.2003
(Calculated value: exact mass = 682.908, molecular weight = 682.8016)
Anal. calcd for C 46 H 36 F 2 N 4: C, 80.92; H, 5.31; F, 5.56; N, 8.21.
Anal. calcd for C 46 H 40 F 2 N 4 · 0.25CHCl 3: C, 77.95; H, 5.13; Cl, 3.73; F, 5.33; N, 7.86.
Found: C, 77.57; H, 5.23; N, 7.87.
合成例2−7(6BCPy−BN−OX) Synthesis Example 2-7 (6BCPy-BN-OX)
反応容器に6BCPy−BNを96.1mg(0.103mmol)入れ、ジクロロメタン80.0mlに溶解させたのちアセトニトリル20.0mlを加えた。ヨウ素(I2)165.3mg(0.651mmol)を加え、1.5時間光を当てつづけ攪拌した。
反応後、亜硝酸ナトリウム水溶液でクエンチ、ジクロロメタンで抽出、水、飽和食塩水で洗浄したのち、乾燥硫酸ナトリウムを用いて乾燥させ、減圧濃縮した。得られた反応物の粗収量は65.1mgであった。
96.1 mg (0.103 mmol) of 6BCPy-BN was placed in a reaction vessel, dissolved in 80.0 ml of dichloromethane, and then 20.0 ml of acetonitrile was added. Iodine (I 2 ) 165.3 mg (0.651 mmol) was added, and the mixture was stirred for 1.5 hours.
After the reaction, the reaction mixture was quenched with an aqueous sodium nitrite solution, extracted with dichloromethane, washed with water and saturated brine, dried over dry sodium sulfate, and concentrated under reduced pressure. The crude yield of the reaction product obtained was 65.1 mg.
合成例2−8(2,4,6−Py−3,5−(n−Pen)Py−ピリジン−OX) Synthesis Example 2-8 (2,4,6-Py-3,5- (n-Pen) Py-pyridine-OX)
5ml反応容器に2,4,6−Py−3,5−(n−Pen)Py−ピリジンを0.10g(0.15mmol)、ジクロロメタンを3g量りとった後、攪拌し均一の溶液とした。この反応溶液にヨウ素のジクロロメタン溶液<ヨウ素(I2)0.30g(1.18mmol)をジクロロメタン3gで溶解させた>を撹拌下加えた後、UVランプで光を10時間照射した。
照射後、亜硫酸水素ナトリウム水溶液で反応をクエンチし、さらに反応液にクロロホルムと水を加え、有機層の水による洗浄操作を3回行った。有機層は無水硫酸ナトリウムを用いて乾燥し、エバポレーターで濃縮した後シリカゲルカラムクロマトグラフィー(クロロホルム/ヘキサン)により精製したところ、式(2−1)で表される化合物を0.02g(0.03mmol,収率20mol%,オレンジ色固体)、式(2−2)で表される化合物を0.005g(0.007mmol,4.9mol%,赤茶色固体)得た。
In a 5 ml reaction vessel, 0.10 g (0.15 mmol) of 2,4,6-Py-3,5- (n-Pen) Py-pyridine and 3 g of dichloromethane were weighed and stirred to obtain a homogeneous solution. To this reaction solution, a dichloromethane solution of iodine <0.30 g (1.18 mmol) of iodine (I 2 ) dissolved in 3 g of dichloromethane> was added with stirring, and then irradiated with light with a UV lamp for 10 hours.
After irradiation, the reaction was quenched with an aqueous sodium hydrogen sulfite solution, and chloroform and water were further added to the reaction solution, and the organic layer was washed with water three times. The organic layer was dried using anhydrous sodium sulfate, concentrated with an evaporator, and purified by silica gel column chromatography (chloroform / hexane). As a result, 0.02 g (0.03 mmol) of the compound represented by the formula (2-1) was obtained. , Yield 20 mol%, orange solid), and 0.005 g (0.007 mmol, 4.9 mol%, reddish brown solid) of the compound represented by formula (2-2) was obtained.
得られた化合物(2−1)、化合物(2−2)の分析データは、以下のとおりである。
化合物(2−1):
1H−NMR(CDCl3,400MHz):δ=0.87−0.93(m,12H),1.25−1.42(m,24H),2.30(t,J=7.6Hz,4H),2.62(t,J=8.0Hz,4H),6.40−6.42(m,2H),6.58−6.59(m,2H),6.63−6.64(m,2H),6.76−6.77(m,2H)7.91−7.92(m,2H).
UV−bis(CHCl3):λmax,408nm
化合物(2−2):
1H−NMR(CDCl3,400MHz):δ=0.90−0.95(m,12H),1.25−1.47(m,18H),2.31−2.34(m,2H),2.46−2.49(m,2H)2.62−2.66(m,2H)2.79−2.82(m,2H),2.86−2.90(m,2H),4.17−4.21(m,2H),5.09−5.13(m,2H),5.18(s,1H),5.59(s,1H),6.46−6.47(m,1H),6.62−6.64(m,1H),6.77(t,J=2.0Hz,2H),6.92(t,J=2.0Hz,2H),7.27(s,1H),7.84−7.85(m,1H).
UV−bis(CHCl3):λmax,450、472nm
Analytical data of the obtained compound (2-1) and compound (2-2) are as follows.
Compound (2-1):
1 H-NMR (CDCl 3 , 400 MHz): δ = 0.87-0.93 (m, 12H), 1.25-1.42 (m, 24H), 2.30 (t, J = 7.6 Hz) , 4H), 2.62 (t, J = 8.0 Hz, 4H), 6.40-6.42 (m, 2H), 6.58-6.59 (m, 2H), 6.63-6 .64 (m, 2H), 6.76-6.77 (m, 2H) 7.91-7.92 (m, 2H).
UV-bis (CHCl 3 ): λmax, 408 nm
Compound (2-2):
1 H-NMR (CDCl 3 , 400 MHz): δ = 0.90-0.95 (m, 12H), 1.25-1.47 (m, 18H), 2.31-2.34 (m, 2H) ), 2.46-2.49 (m, 2H) 2.62-2.66 (m, 2H) 2.79-2.82 (m, 2H), 2.86-2.90 (m, 2H) ), 4.17-4.21 (m, 2H), 5.09-5.13 (m, 2H), 5.18 (s, 1H), 5.59 (s, 1H), 6.46- 6.47 (m, 1H), 6.62-6.64 (m, 1H), 6.77 (t, J = 2.0 Hz, 2H), 6.92 (t, J = 2.0 Hz, 2H) ), 7.27 (s, 1H), 7.84-7.85 (m, 1H).
UV-bis (CHCl 3 ): λmax, 450, 472 nm
合成例2−9(2,3,5,6−BCPy−ピリジン−OX) Synthesis Example 2-9 (2,3,5,6-BCPy-pyridine-OX)
20ml反応容器に2,3,5,6−BCPy−ピリジンを0.11g(0.17mmol)、ジクロロメタンを9.4g量りとった後、攪拌し均一の溶液とした。この反応溶液にヨウ素のジクロロメタン溶液<ヨウ素(I2)0.13g(0.51mmol)をジクロロメタン3.9gで溶解させた>を撹拌下加えた後、UVランプで光を10時間照射した。
照射後、亜硫酸水素ナトリウム水溶液で反応をクエンチし、反応液を濾過して不溶分を除いた後、濾液にクロロホルムを加えてから、反応溶液を水で3回洗浄した。有機層は無水硫酸ナトリウムを用いて洗浄した後、濃縮し、シリカゲルカラムクロマトグラフィー(クロロホルム)で精製して、式(2−3)で表される化合物(以下、「2,3,5,6−BCPy−ピリジン−OX」)を0.07g(0.11mmol、収率64mol%)で得た。
In a 20 ml reaction vessel, 0.11 g (0.17 mmol) of 2,3,5,6-BCPy-pyridine and 9.4 g of dichloromethane were weighed and stirred to obtain a uniform solution. To this reaction solution, a dichloromethane solution of iodine <0.13 g (0.51 mmol) of iodine (I 2 ) was dissolved in 3.9 g of dichloromethane> was added with stirring, and then irradiated with light with a UV lamp for 10 hours.
After the irradiation, the reaction was quenched with an aqueous sodium hydrogen sulfite solution, the reaction solution was filtered to remove insolubles, chloroform was added to the filtrate, and the reaction solution was washed with water three times. The organic layer was washed with anhydrous sodium sulfate, concentrated and purified by silica gel column chromatography (chloroform) to obtain a compound represented by the formula (2-3) (hereinafter “2, 3, 5, 6”). -BCPy-pyridine-OX ") was obtained in 0.07 g (0.11 mmol, yield 64 mol%).
得られた2,3,5,6−BCPy−ピリジン−OXの分析データは、以下のとおりである。
1H−NMR(CDCl3,400MHz):δ=1.56−1.71(m,16H),3.95−3.99(m,4H),4.41−4.48(m,4H),6.57−6.64(m,8H),7.10(s,2H),7.65(s,2H),7.74(s,1H).
Analytical data of the obtained 2,3,5,6-BCPy-pyridine-OX are as follows.
1 H-NMR (CDCl 3 , 400 MHz): δ = 1.56-1.71 (m, 16H), 3.95-3.99 (m, 4H), 4.41-4.48 (m, 4H) ), 6.57-6.64 (m, 8H), 7.10 (s, 2H), 7.65 (s, 2H), 7.74 (s, 1H).
3.共役系の拡張
合成例3−1(2,3,5,6−BCPy−TPN−OXの熱分解反応)
3. Expansion of conjugated system Synthesis example 3-1 (thermal decomposition reaction of 2,3,5,6-BCPy-TPN-OX)
上記で得た2,3,5,6−BCPy−TPN−OX13.9mg(0.02mmol)を300℃で30分間熱処理することにより、式(1−8)で表される化合物11.4mg(0.0196mmol、収率98mol%)を得た。
得られた化合物(1−8)の分析データは、以下のとおりである。
MS(MALDI−TOF)m/z=585.5077
(計算値:精密質量=584.1749,分子量=584.6270)
By heat-treating 2,3,5,6-BCPy-TPN-OX 13.9 mg (0.02 mmol) obtained above at 300 ° C. for 30 minutes, 11.4 mg of the compound represented by the formula (1-8) ( 0.0196 mmol, yield 98 mol%).
The analytical data of the obtained compound (1-8) are as follows.
MS (MALDI-TOF) m / z = 585.5077
(Calculated value: exact mass = 584.1749, molecular weight = 584.6270)
合成例3−2(2,3,5,6−BCPy−1,4−DF−BN−OXの熱分解反応) Synthesis Example 3-2 (2,3,5,6-BCPy-1,4-DF-BN-OX thermal decomposition reaction)
上記で得た2,3,5,6−BCPy−1,4−DF−BN−OX18.5mg(0.027mmol)を300℃で30分間熱処理することにより、式(1−9)で表される化合物14.8mg(0.026mmol、収率96mol%)を得た。
得られた化合物(1−9)の分析データは、以下のとおりである。
UV−bis(CH2Cl2):λmax,441、437、303nm
MS(MALDI−TOF)m/z=570.4421
(計算値:精密質量=570.1656,分子量=570.5890)
Anal. calcd for C46H40F2N4・1/2H2O:C,79.99;H,3.53;F,6.66;N,9.82
Found:C,79.69;H,3.60;N,9.63
By heat-treating 18.5 mg (0.027 mmol) of 2,3,5,6-BCPy-1,4-DF-BN-OX obtained above at 300 ° C. for 30 minutes, it is represented by the formula (1-9). 14.8 mg (0.026 mmol, yield 96 mol%) of the above compound was obtained.
The analytical data of the obtained compound (1-9) are as follows.
UV-bis (CH 2 Cl 2 ): λmax, 441, 437, 303 nm
MS (MALDI-TOF) m / z = 570.421
(Calculated value: exact mass = 570.1656, molecular weight = 570.5890)
Anal. calcd for C 46 H 40 F 2 N 4 · 1 / 2H 2 O: C, 79.99; H, 3.53; F, 6.66; N, 9.82
Found: C, 79.69; H, 3.60; N, 9.63
本発明の高共役化合物は、有機電界効果型トランジスタ、導電性材料として有用である。 The highly conjugated compound of the present invention is useful as an organic field effect transistor or a conductive material.
Claims (7)
[式(1)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい脂肪族炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい脂肪族炭化水素基の組を表し、これらのハロゲン化していてもよい脂肪族炭化水素基は互いに結合して環構造を形成してもよい。
Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。
A1〜A4は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(3)で示される置換基を表す。]
[式(2a)、(2b)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい炭化水素基の組を表し、これらのハロゲン化していてもよい炭化水素基は互いに結合して環構造を形成してもよい。
Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。
A1〜A3は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(3)で示される置換基を表す。]
[式(3)中、R5、R6は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。
Xは水素原子を表すか、近接するX−X間で炭素−炭素結合を形成する。
*は結合位置を表す。
なお、A1〜A4の複数が式(3)で示される置換基のとき、複数のR5はそれぞれ同一でも異なっていてもよく、複数のR6はそれぞれ同一でも異なっていてもよい。] A highly conjugated compound represented by formula (1), formula (2a) or formula (2b).
Wherein (1), R 1 ~R 4 are the same or different, represent a hydrogen atom or a halogenated optionally an aliphatic hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of aliphatic hydrocarbon groups which may be halogenated, and these aliphatic hydrocarbon groups which may be halogenated are bonded to each other. Thus, a ring structure may be formed.
X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX.
A 1 to A 4 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (3). ]
[In formulas (2a) and (2b), R 1 to R 4 are the same or different and each represents a hydrogen atom or an optionally halogenated hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of hydrocarbon groups which may be halogenated, and these hydrocarbon groups which may be halogenated are bonded to each other to form a ring structure. May be formed.
X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX.
A 1 to A 3 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (3). ]
[In Formula (3), R 5 and R 6 are the same or different and represent a hydrogen atom or a hydrocarbon group which may be halogenated, and may be bonded to each other to form a ring structure.
X represents a hydrogen atom or forms a carbon-carbon bond between adjacent XX.
* Represents a bonding position.
Note that when substituents plurality of A 1 to A 4 is represented by the formula (3), a plurality of R 5 may be the same or different, may be different in each of a plurality of R 6 are the same. ]
[式(4a)〜(4c)中、**はR1〜R6の結合位置を表す。
D1、D2は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6a)で表される置換基を示す。]
[式(6a)中、**はR5、R6の結合位置を表す。
*は結合位置を表す。] The highly conjugated compound according to claim 1, wherein the compound represented by the formula (1) has a skeleton other than R 1 to R 6 corresponding to the formulas (4a) to (4c).
[In the formulas (4a) to (4c), ** represents a bonding position of R 1 to R 6 .
D 1 and D 2 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6a). ]
[In the formula (6a), ** represents the bonding position of R 5 and R 6 .
* Represents a bonding position. ]
[式(5a)〜(5c)中、**はR1〜R6の結合位置を示す。
D1は、水素原子、フッ素原子、シアノ基、又は、式(6a)で表される置換基を示す。] The highly conjugated compound according to claim 1, wherein the compound represented by the formula (2a) or the formula (2b) has a skeleton other than R 1 to R 6 corresponding to the formulas (5a) to (5c).
[In the formulas (5a) to (5c), ** represents the bonding position of R 1 to R 6 .
D 1 represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6a). ]
[式(7a)、(7b)中、*は結合位置を示す。] The ring structure formed by R 1 and R 2 , R 3 and R 4 , or R 5 and R 6 is represented by formula (7a) or formula (7b). Highly conjugated compounds as described.
[In formulas (7a) and (7b), * indicates a bonding position. ]
[式(8)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい脂肪族炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい脂肪族炭化水素基の組を表し、これらのハロゲン化していてもよい脂肪族炭化水素基は互いに結合して環構造を形成してもよい。
F1〜F4は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6)で示される置換基を表す。]
[式(9a)、(9b)中、R1〜R4は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表す。なお、R1とR2又はR3とR4の少なくとも1組はハロゲン化していてもよい炭化水素基の組を表し、これらのハロゲン化していてもよい炭化水素基は互いに結合して環構造を形成してもよい。
F1〜F3は、同一又は異なって、水素原子、フッ素原子、シアノ基、又は、式(6)で示される置換基を表す。]
[式(6)中、R5、R6は水素原子又はハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。
*は結合位置を表す。
なお、F1〜F4の複数が式(6)で示される置換基のとき、複数のR5はそれぞれ同一でも異なっていてもよく、複数のR6はそれぞれ同一でも異なっていてもよい。] A highly conjugated compound precursor represented by formula (8), formula (9a), or formula (9b):
[In Formula (8), R < 1 > -R < 4 > is the same or different, and represents the aliphatic hydrocarbon group which may be a hydrogen atom or halogenated. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of aliphatic hydrocarbon groups which may be halogenated, and these aliphatic hydrocarbon groups which may be halogenated are bonded to each other. Thus, a ring structure may be formed.
F 1 to F 4 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6). ]
[In the formulas (9a) and (9b), R 1 to R 4 are the same or different and each represents a hydrogen atom or an optionally halogenated hydrocarbon group. Note that at least one pair of R 1 and R 2 or R 3 and R 4 represents a group of hydrocarbon groups which may be halogenated, and these hydrocarbon groups which may be halogenated are bonded to each other to form a ring structure. May be formed.
F 1 to F 3 are the same or different and each represents a hydrogen atom, a fluorine atom, a cyano group, or a substituent represented by the formula (6). ]
[In formula (6), R 5 and R 6 represent a hydrogen atom or a hydrocarbon group which may be halogenated, and may be bonded to each other to form a ring structure.
* Represents a bonding position.
Note that when substituents plurality of F 1 to F 4 are represented by the formula (6), a plurality of R 5 may be the same or different, may be different in each of a plurality of R 6 are the same. ]
[式(10)、(11)中、E1〜E6は、同一又は異なって、水素原子、フッ素原子、塩素原子、又は、シアノ基を表す。]
[式(12a)〜(12c)中、R1〜R6は、同一又は異なって、水素原子又はハロゲン化していてもよい炭化水素基を表しており、互いに結合して環構造を形成してもよい。] Two or more of the compounds represented by formula (10) or (11) and the compounds represented by formulas (12a) to (12c) (provided that the compound is represented by formula (12a) and formula (12b)) Compound is necessarily included), and after synthesizing a highly conjugated compound precursor represented by the formula (8), formula (9a) or formula (9b), the highly conjugated compound precursor is oxidized to give the formula (1 ), A highly conjugated compound represented by the formula (2a) or the formula (2b), and a method for producing a highly conjugated compound.
[In the formulas (10) and (11), E 1 to E 6 are the same or different and each represents a hydrogen atom, a fluorine atom, a chlorine atom, or a cyano group. ]
[In the formulas (12a) to (12c), R 1 to R 6 are the same or different and each represents a hydrogen atom or a hydrocarbon group which may be halogenated and bonded to each other to form a ring structure. Also good. ]
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010028231A JP2011162490A (en) | 2010-02-10 | 2010-02-10 | Highly-conjugated compound, precursor thereof, and method for producing highly-conjugated compound |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2010028231A JP2011162490A (en) | 2010-02-10 | 2010-02-10 | Highly-conjugated compound, precursor thereof, and method for producing highly-conjugated compound |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JP2011162490A true JP2011162490A (en) | 2011-08-25 |
Family
ID=44593602
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2010028231A Withdrawn JP2011162490A (en) | 2010-02-10 | 2010-02-10 | Highly-conjugated compound, precursor thereof, and method for producing highly-conjugated compound |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2011162490A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016124704A1 (en) * | 2015-02-06 | 2016-08-11 | Technische Universität Dresden | Blue fluorescent emitters |
-
2010
- 2010-02-10 JP JP2010028231A patent/JP2011162490A/en not_active Withdrawn
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2016124704A1 (en) * | 2015-02-06 | 2016-08-11 | Technische Universität Dresden | Blue fluorescent emitters |
| CN107454897A (en) * | 2015-02-06 | 2017-12-08 | 德累斯顿工业技术大学 | blue fluorescent emitter |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN110483460B (en) | A kind of preparation method of 3-selenocoumarin compounds | |
| CN105801575B (en) | A kind of synthetic method of imidazo [1,2-a] pyridine | |
| JP2019214584A (en) | Halogenated compound and production method of fullerene derivative | |
| JP2008063278A (en) | Method for producing 1-pyridin-4-yl-indole | |
| JP2011162490A (en) | Highly-conjugated compound, precursor thereof, and method for producing highly-conjugated compound | |
| JP2009275003A (en) | Method for producing dicyanomethylene derivative | |
| CN117247348B (en) | A preparation method of 3-fluoro-4-aminopyridine | |
| JP5317084B2 (en) | π-conjugated cyclic compound and process for producing the same | |
| CN101798282A (en) | Multi-substituted fluorine-containing pyridine | |
| JP5207516B2 (en) | Method for producing 2,3-dicyanonaphthalene derivative | |
| JP5288779B2 (en) | 2,3-dicyanonaphthalene derivative | |
| Ambre et al. | Toward carboxylate group functionalized A4, A2B2, A3B oxaporphyrins and zinc complex of oxaporphyrins | |
| CN106795080B (en) | Process for the preparation of halogenated trifluoroacetophenones | |
| JP5274805B2 (en) | Method for producing fluorinated aromatic compound | |
| JP7672653B2 (en) | Compound and method for producing same | |
| Van Gioi et al. | Gram-scale nucleophilic aromatic substitution of 4, 7-dibromo-5, 6-difluoro-[2, 1, 3]-benzothiadiazole for Synthesis of 4, 7-dibromo-5, 6-BINOL-O-benzo [2, 1, 3] thiadiazole, and 4, 7-dibromo-5, 6-dicarbazol-N-ylbenzo [2, 1, 3] thiadiazole. The Stille coupling reaction and continuous Heck coupling reaction for synthesis of 4, 7-bispara-chlorophenyl-5, 6-dicarbazol-N-ylbenzo [2, 1, 3] thiadiazole | |
| CN111285880A (en) | Preparation and application of a switch compound containing double crown ether | |
| CN117486880B (en) | A method for preparing fused-ring aromatic hydrocarbons by intercalating pyrrole and pyridine into perylene and their applications | |
| KR101251625B1 (en) | Novel manufacturing method of dutasteride using novel intermediates | |
| JP2013163663A (en) | Method for producing fused ring compound | |
| CN109970643A (en) | A kind of green synthesis method of tetrahydroacridine compound under the promotion of iodine anion | |
| CN112521397B (en) | Preparation method of 2, 6-dioxabicyclo- (3.3.0) -octane-3, 7-dione | |
| JP5858416B2 (en) | Quinoid type carbon-bridged phenylene vinylene compound and method for stabilizing quinoid type phenylene vinylene compound | |
| CN117720467A (en) | Preparation method of surface chiral [2.2] cycloquinoline imitation catalyst | |
| CN112358437B (en) | Method for synthesizing 4,4' -bis (9H-carbazole-9-yl) biphenyl compound in one step |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A300 | Withdrawal of application because of no request for examination |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 20130507 |